Life Extension Final Clerance Sale

Life Extension Magazine

Online References for Life Extension Magazine

November 2003 - As We See It: Startling New Findings About Homocysteine - Reference 14

Abdel-Raheem MM, Hebert B, Potti A, Koka VK, Danielson BD. Hyperhomocysteinemia and the risk of thromboembolic phenomenon in patients with chronic renal failure. Thromb Res. 2002 Feb 15;105(4):299-302.

Acevedo M, Tagle R, Simpfendorfer C. Non-traditional risk factors for atherosclerosis. Rev Med Chil. 2001 Oct;129(10):1212-21. Review.

Adachi H, Hirai Y, Fujiura Y, Matsuoka H, Satoh A, Imaizumi T. Plasma homocysteine levels and atherosclerosis in Japan: epidemiological study by use of carotid ultrasonography. Stroke. 2002 Sep;33(9):2177-81.

Agarwala KL, Kokame K, Kato H, Miyata T. Phosphorylation of RTP, an ER stress-responsive cytoplasmic protein. Biochem Biophys Res Commun. 2000 Jun 16;272(3):641-7.

Aisen PS, Egelko S, Andrews H, Diaz-Arrastia R, Weiner M, DeCarli C, Jagust W, Miller JW, Green R, Bell K, Sano M. A pilot study of vitamins to lower plasma homocysteine levels in Alzheimer disease. Am J Geriatr Psychiatry. 2003 Mar-Apr;11(2):246-9.

Aksu K, Turgan N, Oksel F, Keser G, Ozmen D, Kitapcioglu G, Gumusdis G, Bayindir O, Doganavsargil E. Hyperhomocysteinaemia in Behcet's disease. Rheumatology (Oxford). 2001 Jun;40(6):687-90.

Aleman G, Tovar AR, Torres N. [Homocysteine metabolism and risk of cardiovascular diseases: importance of the nutritional status on folic acid, vitamins B6 and B12] Rev Invest Clin. 2001 Mar-Apr;53(2):141-51. Review. Spanish. Erratum in: Rev Invest Clin 2001 Jul-Aug;53(4):378.

Alfonso Cano C, Vez Garcia MD, Garcia Urruticoechea P, Tornel Osorio PL, Canteras Jordana M, Abellan Aleman J. [Influence of estrogen replacement therapy on therogenic profile in postmenopausal women] An Med Interna. 2003 Feb;20(2):70-4. Spanish.

Ames PR, Margarita A, Delgado Alves J, Tommasino C, Iannaccone L, Brancaccio V. Anticardiolipin antibody titre and plasma homocysteine level independently predict intima media thickness of carotid arteries in subjects with idiopathic antiphospholipid antibodies. Lupus. 2002;11(4):208-14. Anand SS, Yusuf S, Vuksan V, Devanesen S, Teo KK, Montague PA, Kelemen L, Yi C, Lonn E, Gerstein H, Hegele RA. Differences in risk factors, atherosclerosis and cardiovascular disease between ethnic groups in Canada: the study of health assessment and risk in ethnic groups (SHARE). Indian Heart J. 2000 Nov-Dec;52(7 Suppl):S35-43.

Anand SS, Yusuf S, Vuksan V, Devanesen S, Teo KK, Montague PA, Kelemen L, Yi C, Lonn E, Gerstein H, Hegele RA, McQueen M. Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE) Lancet. 2000 Jul 22;356(9226):279-84.

Anderson JL, Horne BD, Carlquist JF, Bair TL, Habashi J, Hart NI, Jones SK, Muhlestein JB; Intermountain Heart Collaborative Study Group. Effect of implementation of folic acid fortification of food on homocysteine concentrations in subjects with coronary artery disease. Am J Cardiol. 2002 Sep 1;90(5):536-9.

Andersson A, Hutlberg B, Lindgren A. Redox status of plasma homocysteine and other plasma thiols in stroke patients. Atherosclerosis. 2000 Aug;151(2):535-9.

Andreassi MG, Botto N, Cocci F, Battaglia D, Antonioli E, Masetti S, Manfredi S, Colombo MG, Biagini A, Clerico A. Methylenetetrahydrofolate reductase gene C677T polymorphism, homocysteine, vitamin B12, and DNA damage in coronary artery disease. Hum Genet. 2003 Feb;112(2):171-7. Epub 2002 Nov 13.

Apostolova MD, Bontchev PR, Ivanova BB, Russell WR, Mehandjiev DR, Beattie JH, Nachev CK. Copper-homocysteine complexes and potential physiological actions. J Inorg Biochem. 2003 Jul 1;95(4):321-33.

Aro A. [Homocysteine and coronary artery disease] Duodecim. 2003;119(12):1131-5. Review. Finnish. Aronow WS. Association between plasma homocysteine and vascular atherosclerotic disease in older persons. Prev Cardiol. 2000 Spring;3(2):89-91.

Asnani S, Desouza C, Homan J, Murthy SN, McNamara DB, Fonseca V. Hormones and homocysteine. Minerva Endocrinol. 2002 Sep;27(3):141-55. Review.

Atherosclerosis, Thrombosis, and Vascular Biology Italian Study Group. No evidence of association between prothrombotic gene polymorphisms and the development of acute myocardial infarction at a young age. Circulation. 2003 Mar 4;107(8):1117-22.

Auer J, Berent R, Weber T, Lassnig E, Eber B. [Homocysteine and cardiovascular risk] Wien Med Wochenschr. 2001;151(1-2):25-8. Review. German.

Auer J, Rammer M, Berent R, Weber T, Lassnig E, Eber B. Body iron stores and coronary atherosclerosis assessed by coronary angiography. Nutr Metab Cardiovasc Dis. 2002 Oct;12(5):285-90.

Barbaux S, Plomin R, Whitehead AS. Polymorphisms of genes controlling homocysteine/folate metabolism and cognitive function. Neuroreport. 2000 Apr 7;11(5):1133-6.

Bauman WA, Adkins RH, Spungen AM, Waters RL, Kemp B, Herbert V. Levels of plasma homocysteine in persons with spinal cord injury. J Spinal Cord Med. 2001 Summer;24(2):81-6.

Baydas G, Kutlu S, Naziroglu M, Canpolat S, Sandal S, Ozcan M, Kelestimur H. Inhibitory effects of melatonin on neural lipid peroxidation induced by intracerebroventricularly administered homocysteine. J Pineal Res. 2003 Jan;34(1):36-9.

Bayes B, Pastor MC, Bonal J, Junca J, Romero R. Homocysteine and lipid peroxidation in haemodialysis: role of folinic acid and vitamin E. Nephrol Dial Transplant. 2001 Nov;16(11):2172-5.

Beaudeux JL, Jacob N, Giral P, Foglietti MJ, Bruckert E. [New non-lipidic biological markers of atherosclerosis] Ann Med Interne (Paris). 2001 Apr;152(3):169-79. Review. French.

Bekpinar S, Kocak H, Unlucerci Y, Genc S, Akdag-Kose A, Gogus F. The evaluation of C-reactive protein, homocysteine and vitamin B(6) concentrations in Behcet and rheumatoid arthritis disease. Clin Chim Acta. 2003 Mar;329(1-2):143-5.

Bell IR, Edman JS, Selhub J, Morrow FD, Marby DW, Kayne HL, Cole JO. Plasma homocysteine in vascular disease and in nonvascular dementia of depressed elderly people. Acta Psychiatr Scand. 1992 Nov;86(5):386-90.

Benmerabet S, Fredenrich A, Robillon JF, Canivet B, Candito M, Van Obberghen E. [Clinical relevance of homocysteine monitoring in the diabetic patient] Diabetes Metab. 2002 Dec;28(6 Pt 1):510-5. Review. French.

Bernard MA, Nakonezny PA, Kashner TM. The effect of vitamin B12 deficiency on older veterans and its relationship to health. J Am Geriatr Soc. 1998 Oct;46(10):1199-206.

Berrino F. [Western diet and Alzheimer's disease] Epidemiol Prev. 2002 May-Jun;26(3):107-15. Review. Italian. Bertsch T, Mielke O, Holy S, Zimmer W, Casarin W, Aufenanger J, Walter S, Muehlhauser F, Kuehl S, Ragoschke A, Fassbender K. Homocysteine in cerebrovascular disease: an independent risk factor for subcortical vascular encephalopathy. Clin Chem Lab Med. 2001 Aug;39(8):721-4.

Bessede G, Miguet C, Gambert P, Neel D, Lizard G. Efficiency of homocysteine plus copper in inducing apoptosis is inversely proportional to gamma-glutamyl transpeptidase activity. FASEB J. 2001 Sep;15(11):1927-40.

Biasioli S, Schiavon R, Petrosino L, Cavallini L, Cavalcanti G, De Fanti E, Zambello A, Borin D. Role of cellulosic and noncellulosic membranes in hyperhomocysteinemia and oxidative stress. ASAIO J. 2000 Sep-Oct;46(5):625-34.

Biasioli S, Schiavon R, Petrosino L, Cavallini L, De Fanti E, Zambello A, Borin D, Targa L. Do different dialytic techniques have different atherosclerotic and antioxidant activities? ASAIO J. 2001 Sep-Oct;47(5):516-21.

Bibliography. Current world literature. Nutrition and metabolism. Curr Opin Lipidol. 2002 Feb;13(1):75-85.

Bicikova M, Tallova J, Stanicka S, Hill M, Vondra K, Hampl R. Levels of testosterone, allopregnanolone and homocysteine in severe hypothyroidism. Clin Chem Lab Med. 2002 Oct;40(10):1024-7.

Billion S, Tribout B, Cadet E, Queinnec C, Rochette J, Wheatley P, Bataille P. Hyperhomocysteinaemia, folate and vitamin B12 in unsupplemented haemodialysis patients: effect of oral therapy with folic acid and vitamin B12. Nephrol Dial Transplant. 2002 Mar;17(3):455-61.

Bissonnette R, Treacy E, Rozen R, Boucher B, Cohn JS, Genest J Jr. Fenofibrate raises plasma homocysteine levels in the fasted and fed states. Atherosclerosis. 2001 Apr;155(2):455-62.

Bjorke Monsen AL, Ueland PM. Homocysteine and methylmalonic acid in diagnosis and risk assessment from infancy to adolescence. Am J Clin Nutr. 2003 Jul;78(1):7-21. Review. Bjelland I, Tell GS, Vollset SE, Refsum H, Ueland PM. olate, vitamin B12, homocysteine, and the MTHFR 677C->T polymorphism in anxiety and depression: the Hordaland Homocysteine Study. Arch Gen Psychiatry. 2003 Jun;60(6):618-26.

Black PH, Garbutt LD. Stress, inflammation and cardiovascular disease. J Psychosom Res. 2002 Jan;52(1):1-23. Review.

Bloemenkamp DG, van den Bosch MA, Mali WP, Tanis BC, Rosendaal FR Kemmeren JM, Algra A, Visseren FL, van der Graaf Y. Novel risk factors for peripheral arterial disease in young women. Am J Med. 2002 Oct 15;113(6):462-7.

Bloemenkamp DG, Mali WP, Tanis BC, Rosendaal FR, van den Bosch MA, Kemmeren JM, Algra A, Visseren FL, van der Graaf Y. The relation between Helicobacter pylori and atherosclerosis cannot be explained by a high homocysteine concentration. Eur J Clin Invest. 2002 Aug;32(8):549-55. Blom HJ. Consequences of homocysteine export and oxidation in the vascular system. Semin Thromb Hemost. 2000;26(3):227-32. Review.

Blum A, Lupovitch S, Khazim K, Peleg A, Gumanovsky M, Yeganeh S, Jawabreh S. Homocysteine levels in patients with risk factors for atherosclerosis. Clin Cardiol. 2001 Jun;24(6):463-6.

Bode MK, Laitinen P, Risteli J, Uusimaa P, Juvonen T. Atherosclerosis, type 1 collagen cross-linking and homocysteine. Atherosclerosis. 2000 Oct;152(2):531-2.

Boers GH. Mild hyperhomocysteinemia is an independent risk factor of arterial vascular disease. Semin Thromb Hemost. 2000;26(3):291-5. Review.

Boger RH, Sydow K, Borlak J, Thum T, Lenzen H, Schubert B, Tsikas D, Bode-Boger SM. LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases. Circ Res. 2000 Jul 21;87(2):99-105.

Bomalaski PS. Homocysteine: a risk factor of atherosclerosis. Nurse Pract. 2000 Apr;25(4):129-31.

Booth GL, Wang EE. Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. The Canadian Task Force on Preventive Health Care. CMAJ. 2000 Jul 11;163(1):21-9.

Bopp-Kistler I, Ruegger-Frey B, Grob D, Six P. [Vitamin B12 deficiency in geriatrics] Schweiz Rundsch Med Prax. 1999 Nov 4;88(45):1867-75. Review. German.

Bostom AG. Homocysteine: "expensive creatinine" or important modifiable risk factor for arteriosclerotic outcomes in renal transplant recipients? J Am Soc Nephrol. 2000 Jan;11(1):149-51. Review.

Bostom AG, Garber C. Endpoints for homocysteine-lowering trials. Lancet. 2000 Feb 12;355(9203):511-2.

Bostom AG, Shemin D, Gohh RY, Beaulieu AJ, Bagley P, Massy ZA, Jacques PF, Dworkin L, Selhub J. Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients. Kidney Int Suppl. 2001 Feb;78:S246-52.

Bostom AG, Jacques PF, Liaugaudas G, Rogers G, Rosenberg IH, Selhub J. Total homocysteine lowering treatment among coronary artery disease patients in the era of folic acid-fortified cereal grain flour. Arterioscler Thromb Vasc Biol. 2002 Mar 1;22(3):488-91.

Bottiglieri T, Parnetti L, Arning E, Ortiz T, Amici S, Lanari A, Gallai V. Plasma total homocysteine levels and the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene: a study in an Italian population with dementia. Mech Ageing Dev. 2001 Nov;122(16):2013-23.

Bowirrat A, Friedland RP, Farrer L, Baldwin C, Korczyn A. Genetic and environmental risk factors for Alzheimer's disease in Israeli Arabs. J Mol Neurosci. 2002 Aug-Oct;19(1-2):239-45.

Bozkurt A, Toyaksi H, Acarturk E, Tuli A, Cayli M. The effects of hyperhomocysteinemia on the presence, extent, and severity of coronary artery disease. Jpn Heart J. 2003 May;44(3):357-68. Brattstrom L, Wilcken DE. Homocysteine and cardiovascular disease: cause or effect? Am J Clin Nutr. 2000 Aug;72(2):315-23. Review.

Bremner WF, Holmes EW, Kanabrocki EL, Hermida RC, Ayala D, Garbincius J, Third JL, Ryan MD, Johnson M, Foley S, Shirazi P, Nemchausky BA, Scheving LE. Circadian rhythm of serum total homocysteine in men. Am J Cardiol. 2000 Nov 15;86(10):1153-6, A9-10.

Breteler MM. Vascular involvement in cognitive decline and dementia. Epidemiologic evidence from the Rotterdam Study and the Rotterdam Scan Study. Ann N Y Acad Sci. 2000 Apr;903:457-65.

Brodaty H, Ames D, Boundy KL, Hecker J, Snowdon J, Storey E, Yates MW. Pharmacological treatment of cognitive deficits in Alzheimer's disease. Med J Aust. 2001 Sep 17;175(6):324-9. Review.

Brunelli T, Prisco D, Fedi S, Rogolino A, Farsi A, Marcucci R, Giusti B, Pratesi C, Pulli R, Gensini GF, Abbate R, Pepe G. High prevalence of mild hyperhomocysteinemia in patients with abdominal aortic aneurysm. J Vasc Surg. 2000 Sep;32(3):531-6.

Brzosko S, Hryszko T, Malyszko J, Mysliwiec M. [Homocysteine--new risk factor for progression of atherosclerosis and its complications] Pol Merkuriusz Lek. 2001 Jan;10(55):56-9. Review. Polish.

Buccianti G, Bamonti Catena F, Patrosso C, Corghi E, Novembrino C, Baragetti I, Lando G, De Franceschi M, Maiolo AT. Reduction of the homocysteine plasma concentration by intravenously administered folinic acid and vitamin B(12) in uraemic patients on maintenance haemodialysis. Am J Nephrol. 2001 Jul-Aug;21(4):294-9.

Buccianti G, Raselli S, Baragetti I, Bamonti F, Corghi E, Novembrino C, Patrosso C, Maggi FM, Catapano AL. 5-methyltetrahydrofolate restores endothelial function in uraemic patients on convective haemodialysis. Nephrol Dial Transplant. 2002 May;17(5):857-64.

Budge M, Johnston C, Hogervorst E, de Jager C, Milwain E, Iversen SD, Barnetson L, King E, Smith AD. Plasma total homocysteine and cognitive performance in a volunteer elderly population. Ann N Y Acad Sci. 2000 Apr;903:407-10.

Budge MM, de Jager C, Hogervorst E, Smith AD; Oxford Project To Investigate Memory and Ageing (OPTIMA). Total plasma homocysteine, age, systolic blood pressure, and cognitive performance in older people. J Am Geriatr Soc. 2002 Dec;50(12):2014-8. Bunout D, Petermann M, Hirsch S, de la Maza P, Suazo M, Barrera G, Kauffman R. Low serum folate but normal homocysteine levels in patients with atherosclerotic vascular disease and matched healthy controls. Nutrition. 2000 Jun;16(6):434-8.

Burke AP, Fonseca V, Kolodgie F, Zieske A, Fink L, Virmani R. Increased serum homocysteine and sudden death resulting from coronary atherosclerosis with fibrous plaques. Arterioscler Thromb Vasc Biol. 2002 Nov 1;22(11):1936-41.

Can C, Cinar MG, Kosay S, Evinc A. Vascular endothelial dysfunction associated with elevated serum homocysteine levels in rat adjuvant arthritis: effect of vitamin E administration. Life Sci. 2002 Jun 14;71(4):401-10.

Carmel R, Gott PS, Waters CH, Cairo K, Green R, Bondareff W, DeGiorgio CM, Cummings JL, Jacobsen DW, Buckwalter G, et al. The frequently low cobalamin levels in dementia usually signify treatable metabolic, neurologic and electrophysiologic abnormalities. Eur J Haematol. 1995 Apr;54(4):245-53.

Carpentier Y. [Atherosclerosis and micronutrients] Rev Med Brux. 2000 Sep;21(4):A363-6. Review. French.

Cattaneo M. Hyperhomocysteinemia and thrombosis. Lipids. 2001;36 Suppl:S13-26. Review.

Cattaneo M. Does tamoxifen enhance endothelial function by lowering the plasma levels of homocysteine? Circulation. 2001 Dec 11;104(24):E146-7.

Cavusoglu E. Editorial comment: plasma homocysteine, coronary risk factors and serum nitrite in coronary artery disease and vascular syndrome X. Anadolu Kardiyol Derg. 2003 Mar;3(1):35-7.

Chai AU, Abrams J. Homocysteine: a new cardiac risk factor? Clin Cardiol. 2001 Jan;24(1):80-4. Review.

Chamberlin ME, Ubagai T, Mudd SH, Thomas J, Pao VY, Nguyen TK, Levy HL, Greene C, Freehauf C, Chou JY. Methionine adenosyltransferase I/III deficiency: novel mutations and clinical variations. Am J Hum Genet. 2000 Feb;66(2):347-55.

Chambers JC, Seddon MD, Shah S, Kooner JS. Homocysteine--a novel risk factor for vascular disease. J R Soc Med. 2001 Jan;94(1):10-3. Review.

Chambers JC, Kooner JS. Homocysteine--an innocent bystander in vascular disease? Eur Heart J. 2001 May;22(9):717-9.

Chen N, Liu Y, Greiner CD, Holtzman JL. Physiologic concentrations of homocysteine inhibit the human plasma GSH peroxidase that reduces organic hydroperoxides. J Lab Clin Med. 2000 Jul;136(1):58-65.

Chen C, Surowiec SM, Morsy AH, Ma M. Intraperitoneal infusion of homocysteine increases intimal hyperplasia in balloon-injured rat carotid arteries. Atherosclerosis. 2002 Jan;160(1):103-14.

Cherkas IuV, Denisenko AD. [Measurement of blood homocysteine by high performance liquid chromatography (HPLC)] Klin Lab Diagn. 2001;(5):35-7. Russian. Chiang EP, Bagley PJ, Selhub J, Nadeau M, Roubenoff R. Abnormal vitamin B(6) status is associated with severity of symptoms in patients with rheumatoid arthritis. Am J Med. 2003 Mar;114(4):283-7.

Chiang EP, Bagley PJ, Roubenoff R, Nadeau M, Selhub J. Plasma pyridoxal 5'-phosphate concentration is correlated with functional vitamin B-6 indices in patients with rheumatoid arthritis and marginal vitamin B-6 status. J Nutr. 2003 Apr;133(4):1056-9.

Chotinaiwattarakul C, Mahanonda N, Bhuripanyo K, Leowattana W, Kangkagate C, Krittayaphong R, Wansanit K, Hongvisitkul C, Pokum S. Prevalence of new coronary risk factors in Thai population. J Med Assoc Thai. 2000 Nov;83 Suppl 2:S172-8.

Cingozbay BY, Yiginer O, Cebeci BS, Kardesoglu E, Demiralp E, Dincturk M. Role of homocysteine for thromboembolic complication in patients with non-valvular atrial fibrilation. Blood Coagul Fibrinolysis. 2002 Oct;13(7):609-13. Cisternas M, Gutierrez MA, Klaassen J, Acosta AM, Jacobelli S. Cardiovascular risk factors in Chilean patients with rheumatoid arthritis. J Rheumatol. 2002 Aug;29(8):1619-22.

Clarke R, Joachim C, Esiri M, Morris J, Bungay H, Molyneux A, Budge M, Frost C, King E, Barnetson L, Smith AD. Leukoaraiosis at presentation and disease progression during follow-up in histologically confirmed cases of dementia. Ann N Y Acad Sci. 2000 Apr;903:497-500.

Clarke R, Harrison G, Richards S; Vital Trial Collaborative Group. Effect of vitamins and aspirin on markers of platelet activation, oxidative stress and homocysteine in people at high risk of dementia. J Intern Med. 2003 Jul;254(1):67-75.

Collins T, Cybulsky MI. NF-kappaB: pivotal mediator or innocent bystander in atherogenesis? J Clin Invest. 2001 Feb;107(3):255-64. Review.

Cook JW, Malinow MR, Moneta GL, Taylor LM, Orloff SL. Neointimal hyperplasia in balloon-injured rat carotid arteries: the influence of hyperhomocysteinemia. J Vasc Surg. 2002 Jan;35(1):158-65.

Cook JW, Taylor LM, Orloff SL, Landry GJ, Moneta GL, Porter JM. Homocysteine and arterial disease. Experimental mechanisms. Vascul Pharmacol. 2002 May;38(5):293-300. Review.

Coppola A, Davi G, De Stefano V, Mancini FP, Cerbone AM, Di Minno G. Homocysteine, coagulation, platelet function, and thrombosis. Semin Thromb Hemost. 2000;26(3):243-54. Review.

Cortelezzi A, Fracchiolla NS, Bamonti-Catena F, Motta M, Cighetti G, Carrabba M, Cavalca V, Maiolo AT, Lambertenghi Deliliers G. Hyperhomocysteinemia in myelodysplastic syndromes: specific association withautoimmunity and cardiovascular disease. Leuk Lymphoma. 2001 Mar;41(1-2):147-50.

Cortese C, Motti C. MTHFR gene polymorphism, homocysteine and cardiovascular disease. Public Health Nutr. 2001 Apr;4(2B):493-7. Review.

Debreceni L. [Homocysteine--a risk factor for atherosclerosis] Orv Hetil. 2001 Jul 8;142(27):1439-44. Review. Hungarian.

de Gomez Dumm NT, Giammona AM, Touceda LA. Variations in the lipid profile of patients with chronic renal failure, treated with folic acid. Int J Vitam Nutr Res. 2003 May;73(3):215-20. Deicher R, Vierhapper H. Homocysteine: a risk factor for cardiovascular disease in subclinical hypothyroidism? Thyroid. 2002 Aug;12(8):733-6.

de Jong S. Hyperhomocysteinaemia in patients with peripheral arterial occlusive disease. Clin Chem Lab Med. 2001 Aug;39(8):714-6. Review.

de la Pena-Diaz A, Izaguirre-Avila R, Angles-Cano E. Lipoprotein Lp(a) and atherothrombotic disease. Arch Med Res. 2000 Jul-Aug;31(4):353-9. Review.

De Leo V, la Marca A, Morgante G, Lanzetta D, Setacci C, Petraglia F. Randomized control study of the effects of raloxifene on serum lipids and homocysteine in older women. Am J Obstet Gynecol. 2001 Feb;184(3):350-3

Delport R. Hyperhomocyst(e)inemia, related vitamins and dementias. J Nutr Health Aging. 2000;4(4):195-6. Review.

de Luis DA, Fernandez N, Arranz M, Aller R, Izaola O. Total homocysteine and cognitive deterioration in people with type 2 diabetes. Diabetes Res Clin Pract. 2002 Mar;55(3):185-90.

de Meer K, Stam F, van Guldener C. Hyperhomocysteinemia and cardiovascular disease. Am J Clin Nutr. 2001 May;73(5):992-3.

Desai A, Lankford HA, Warren JS. Homocysteine augments cytokine-induced chemokine expression in human vascular smooth muscle cells: implications for atherogenesis. Inflammation. 2001 Jun;25(3):179-86.

De Vecchi AF, Bamonti-Catena F, Finazzi S, Patrosso C, Taioli E, Novembrino C, Colucci P, Lando G, De Franceschi M, Marocchi A, Maiolo AT. Homocysteine, vitamin B12, serum and erythrocyte folate in peritoneal dialysis patients. Clin Nephrol. 2001 Apr;55(4):313-7.

Devlin AM, Ling EH, Peerson JM, Fernando S, Clarke R, Smith AD, Halsted CH. Glutamate carboxypeptidase II: a polymorphism associated with lower levels of serum folate and hyperhomocysteinemia.Hum Mol Genet. 2000 Nov 22;9(19):2837-44.

Dierkes J, Westphal S, Luley C. Fenofibrate-induced hyperhomocysteinaemia: clinical implications and management. Drug Saf. 2003;26(2):81-91. Review.

Dimitrova KR, DeGroot K, Myers AK, Kim YD. Estrogen and homocysteine. Cardiovasc Res. 2002 Feb 15;53(3):577-88. Review.

Djuric D, Wisotzki R, Mitrovic V. Homocysteine and arteriosclerosis: established risk factor or new illusion? Am J Ther. 2000 Nov;7(6):381-7. Review.

Doevendans PA, Jukema W, Spiering W, Defesche JC, Kastelein JJ. Molecular genetics and gene expression in atherosclerosis. Int J Cardiol. 2001 Sep-Oct;80(2-3):161-72. Review.

Dong C, Yoon W, Goldschmidt-Clermont PJ. DNA methylation and atherosclerosis. J Nutr. 2002 Aug;132(8 Suppl):2406S-2409S. Review.

Doshi SN, McDowell IF, Moat SJ, Payne N, Durrant HJ, Lewis MJ, Goodfellow J. Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering. Circulation. 2002 Jan 1;105(1):22-6.

Drzewoski J, Czupryniak L, Chwatko G, Bald E. Hyperhomocysteinemia in poorly controlled type 2 diabetes patients. Diabetes Nutr Metab. 2000 Dec;13(6):319-24.

Ducloux D, Motte G, Challier B, Gibey R, Chalopin JM. Serum total homocysteine and cardiovascular disease occurrence in chronic, stable renal transplant recipients: a prospective study. J Am Soc Nephrol. 2000 Jan;11(1):134-7.

Dufouil C, Alperovitch A, Ducros V, Tzourio C. Homocysteine, white matter hyperintensities, and cognition in healthy elderly people. Ann Neurol. 2003 Feb;53(2):214-21.

Duthie SJ, Whalley LJ, Collins AR, Leaper S, Berger K, Deary IJ. Homocysteine, B vitamin status, and cognitive function in the elderly. Am J Clin Nutr. 2002 May;75(5):908-13. Erratum in: Am J Clin Nutr. 2003 Feb;77(2):523.. Dzielinska Z, Kadziela J, Sitkiewicz D, Kruk M, Przyluski J, Deptuch T, Piotrowski W, Dabrowski M, Ruzyllo W. [Elevated levels of homocysteine in plasma as a risk factor for coronary artery disease] Pol Arch Med Wewn. 2000Jul;104(1):345-53. Polish.

Erb N, Kitas GD. Homocysteine modulation as a reason for continuous folic acid supplementation in methotrexate-treated rheumatoid arthritis patients. Rheumatology (Oxford). 2001 Jun;40(6):715-6.

Ebenbichler CF, Kaser S, Bodner J, Gander R, Lechleitner M, Herold M, Patsch JR. Hyperhomocysteinemia in bodybuilders taking anabolic steroids. Eur J Intern Med. 2001 Feb;12(1):43-47.

Eberhardt RT, Forgione MA, Cap A, Leopold JA, Rudd MA, Trolliet M, Heydrick S, Stark R, Klings ES, Moldovan NI, Yaghoubi M, Goldschmidt-Clermont PJ, Farber HW, Cohen R, Loscalzo J. Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia. J Clin Invest. 2000 Aug;106(4):483-91.

Eikelboom JW, Hankey GJ, Anand SS, Lofthouse E, Staples N, Baker RI. Association between high homocyst(e)ine and ischemic stroke due to large- and small-artery disease but not other etiologic subtypes of ischemic stroke. Stroke. 2000 May;31(5):1069-75.

Eikelboom JW, Hankey GJ. Associations of homocysteine, C-reactive protein and cardiovascular disease in patients with renal disease. Curr Opin Nephrol Hypertens. 2001 May;10(3):377-83. Review.

Elisaf M, Mikhailidis DP. Statins and renal function. Angiology. 2002 Sep-Oct;53(5):493-502. Review.

Elisaf M. Effects of fibrates on serum metabolic parameters. Curr Med Res Opin. 2002;18(5):269-76. Review.

Essama-Tjani JC, Guilland JC, Potier de Courcy G, Fuchs F, Richard D. Folate status worsens in recently institutionalized elderly people without evidence of functional deterioration. J Am Coll Nutr. 2000 Jun;19(3):392-404.

Eto K, Asada T, Arima K, Makifuchi T, Kimura H. Brain hydrogen sulfide is severely decreased in Alzheimer's disease. Biochem Biophys Res Commun. 2002 May 24;293(5):1485-8

Facchini FS, Saylor KL. Effect of iron depletion on cardiovascular risk factors: studies in carbohydrate-intolerant patients. Ann N Y Acad Sci. 2002 Jun;967:342-51.

Fagerberg B, Wallenfeldt K, Alenhag EL, Bokemark L, Wikstrand J. High-normal serum homocysteine concentrations are associated with an increased risk of early atherosclerotic carotid artery wall lesions. J Hypertens. 2000 Oct;18(10):1523-5.

Feigin VL, Anderson CS, Mhurchu CN. Systemic inflammation, endothelial dysfunction, dietary fatty acids and micronutrients as risk factors for stroke: a selective review. Cerebrovasc Dis. 2002;13(4):219-24. Review.

Feinstein S, Sela BA, Drukker A, Becker-Cohen R, Raveh D, Gavendo S, Frishberg Y. Hyperhomocysteinemia in children on renal replacement therapy. Pediatr Nephrol. 2002 Jul;17(7):515-9. Epub 2002 Jun 11.

Ferretti G, Bacchetti T, Marotti E, Curatola G. Effect of homocysteinylation on human high-density lipoproteins: a correlation with paraoxonase activity. Metabolism. 2003 Feb;52(2):146-51.

Fiorina P, La Rocca E, Venturini M, Minicucci F, Fermo I, Paroni R, D'Angelo A, Sblendido M, Di Carlo V, Cristallo M, Del Maschio A, Pozza G, Secchi A. Effects of kidney-pancreas transplantation on atherosclerotic risk factors and endothelial function in patients with uremia and type 1 diabetes. Diabetes. 2001 Mar;50(3):496-501.

Fleming RM. The Fleming Unified Theory of Vascular Disease: a link between atherosclerosis, inflammation, and bacterially aggravated atherosclerosis (BAA) Angiology. 2000 Jan;51(1):87-9.

Flemming KD, Nguyen TT, Abu-Lebdeh HS, Parisi JE, Wiebers DO, Sicks JD, O'Fallon WM, Petty GW. Hyperhomocysteinemia in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Mayo Clin Proc. 2001 Dec;76(12):1213-8.

Folsom AR, Desvarieux M, Nieto FJ, Boland LL, Ballantyne CM, Chambless LE. B vitamin status and inflammatory markers. Atherosclerosis. 2003 Jul;169(1):169-74.

Foody JM, Milberg JA, Robinson K, Pearce GL, Jacobsen DW, Sprecher DL. Homocysteine and lipoprotein(a) interact to increase CAD risk in young men and women. Arterioscler Thromb Vasc Biol. 2000 Feb;20(2):493-9.

Forstl H, Lautenschlager N, Bickel H. Mild cognitive impairment: making headway by stepping backwards. Seishin Shinkeigaku Zasshi. 2003;105(4):370-80. Review.

Fridman O. [Hyperhomocysteinemia: atherothrombosis and neurotoxicity] Acta Physiol Pharmacol Ther Latinoam. 1999;49(1):21-30. Review. Spanish.

Friso S, Choi SW, Girelli D, Mason JB, Dolnikowski GG, Bagley PJ, Olivieri O, Jacques PF, Rosenberg IH, Corrocher R, Selhub J. A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc Natl Acad Sci U S A. 2002 Apr 16;99(8):5606-11.

Friso S, Girelli D, Trabetti E, Stranieri C, Olivieri O, Tinazzi E, Martinelli N, Faccini G, Pignatti PF, Corrocher R. A1298C methylenetetrahydrofolate reductase mutation and coronary artery disease: relationships with C677T polymorphism and homocysteine/folate metabolism. Clin Exp Med. 2002 May;2(1):7-12.

Fritsma G. Laboratory results that predict arterial thrombosis. Clin Lab Sci. 2001 Fall;14(4):262-8.

Froberg MK, Seacotte N, Dahlberg E. Cytomegalovirus seropositivity and serum total cholesterol levels in young patients. Ann Clin Lab Sci. 2001 Apr;31(2):157-61.

Frohlich J, Dobiasova M, Lear S, Lee KW. The role of risk factors in the development of atherosclerosis. Crit Rev Clin Lab Sci. 2001 Oct;38(5):401-40. Review.

Frostegard J. Autoimmunity, oxidized LDL and cardiovascular disease. Autoimmun Rev. 2002 Aug;1(4):233-7.

Fuchs D, Jaeger M, Widner B, Wirleitner B, Artner-Dworzak E, Leblhuber F. Is hyperhomocysteinemia due to the oxidative depletion of folate rather than to insufficient dietary intake? Clin Chem Lab Med. 2001 Aug;39(8):691-4.

Fujimoto S, Togane Y, Matsuzaki C, Yamashina S, Nakano H, Yamazaki J, Yoshino G. Effects of long-term administration of methionine on vascular endothelium in rabbits. Nutr Metab Cardiovasc Dis. 2003 Feb;13(1):20-7.

Gao L, Tang CS. [Cellular and molecular mechanism of cardiovascular disease resulting from hyperhomocysteinemia] Sheng Li Ke Xue Jin Zhan. 2002 Oct;33(4):335-8. Review. Chinese.

Garber AJ. Attenuating cardiovascular risk factors in patients with type 2 diabetes. Am Fam Physician. 2000 Dec 15;62(12):2633-42, 2645-6. Review.

Garcia-Tevijano ER, Berasain C, Rodriguez JA, Corrales FJ, Arias R, Martin-Duce A, Caballeria J, Mato JM, Avila MA. Hyperhomocysteinemia in liver cirrhosis: mechanisms and role in vascular and hepatic fibrosis. Hypertension. 2001 Nov;38(5):1217-21.

Genser D, Prachar H, Hauer R, Halbmayer WM, Mlczoch J, Elmadfa I. Relation of homocysteine, vitamin B(12), and folate to coronary in-stent restenosis. Am J Cardiol. 2002 Mar 1;89(5):495-9.

Girelli D, Martinelli N, Pizzolo F, Friso S, Olivieri O, Stranieri C, Trabetti E, Faccini G, Tinazzi E, Pignatti PF, Corrocher R. The interaction between MTHFR 677 C-->T genotype and folate status is a determinant of coronary atherosclerosis risk. J Nutr. 2003 May;133(5):1281-5.

Glowinska B, Urban M, Koput A. [Correlation between body mass index, lipoprotein (a) level and positive family history of cardiovascular diseases in children and adolescents with obesity, hypertension and diabetes] Pol Merkuriusz Lek. 2002 Feb;12(68):108-14. Polish.

Glowinska B, Urban M, Koput A. Cardiovascular risk factors in children with obesity, hypertension and diabetes: lipoprotein(a) levels and body mass index correlate with family history of cardiovascular disease. Eur J Pediatr. 2002 Oct;161(10):511-8. Epub 2002 Aug 30.

Glowinska B, Urban M, Koput A, Galar M. [In Process Citation] Przegl Lek. 2003;60(1):12-7. Polish.

Glowinska B, Urban M, Koput A, Galar M. New atherosclerosis risk factors in obese, hypertensive and diabetic children and adolescents. Atherosclerosis. 2003 Apr;167(2):275-86.

Glueck CJ, Wang P, Fontaine RN, Sieve-Smith L, Lang JE. Interaction of estrogen replacement therapy with the thrombophilic 20210 G/A prothrombin gene mutation for atherothrombotic vascular disease: a cross-sectional study of 275 hyperlipidemic women. Metabolism. 2001 Mar;50(3):360-5. Godsland IF, Winkler U, Lidegaard O, Crook D. Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms. Drugs. 2000 Oct;60(4):721-869. Review.

Gonzalez-Gross M, Marcos A, Pietrzik K. Nutrition and cognitive impairment in the elderly. Br J Nutr. 2001 Sep;86(3):313-21. Review.

Gottfries CG, Lehmann W, Regland B. Early diagnosis of cognitive impairment in the elderly with the focus on Alzheimer's disease. J Neural Transm. 1998;105(8-9):773-86. Review.

Gottfries J, Blennow K, Lehmann MW, Regland B, Gottfries CG. One-carbon metabolism and other biochemical correlates of cognitive impairment as visualized by principal component analysis. J Geriatr Psychiatry Neurol. 2001 Fall;14(3):109-14.

Gottsater A, Forsblad J, Mattiasson I, Lindgarde F. Decreasing plasma endothelin-1 and unchanged plasma neopterin during folate supplementation in hyperhomocysteinemia. Int Angiol. 2002 Jun;21(2):158-64.

Guilland JC, Favier A, Potier de Courcy G, Galan P, Hercberg S. Hyperhomocysteinemia: an independent risk factor or a simple marker of vascular disease?. 1. Basic data] [Article in French] Pathol Biol (Paris). 2003 Mar;51(2):101-10.

Guo X, Dudman NP. Homocysteine alters monocyte-endothelial interaction in vitro. Chin Med J (Engl). 2003 Jan;116(1):34-8.

Gussekloo J, Heijmans BT, Slagboom PE, Lagaay AM, Knook DL, Westendorp RG. Thermolabile methylenetetrahydrofolate reductase gene and the risk of cognitive impairment in those over 85. J Neurol Neurosurg Psychiatry. 1999 Oct;67(4):535-8.

Guyonnet S, Nourhashemi F, Ousset PJ, de Glisezinski I, Riviere D, Albarede JL, Vellas B. [Alzheimer's disease and nutrition] Rev Neurol (Paris). 1999 May;155(5):343-9. Review. French.

Haak E, Abletshauser C, Weber S, Goedicke C, Martin N, Hermanns N, Lackner K, Kusterer K, Usadel KH, Haak T. Fluvastatin therapy improves microcirculation in patients with hyperlipidaemia. Atherosclerosis. 2001 Apr;155(2):395-401.

Hackam DG, Peterson JC, Spence JD. What level of plasma homocyst(e)ine should be treated? Effects of vitamin therapy on progression of carotid atherosclerosis in patients with homocyst(e)ine levels above and below 14 micromol/L. Am J Hypertens. 2000 Jan;13(1 Pt 1):105-10.

Hackam DG, Anand SS. Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence. JAMA. 2003 Aug 20;290(7):932-40. Review.

Hajjar KA. Homocysteine: a sulph'rous fire. J Clin Invest. 2001 Mar;107(6):663-4. Review.

Hallegua DS, Wallace DJ. How accelerated atherosclerosis in SLE has changed our management of the disorder. Lupus. 2000;9(3):228-31. Review.

Haltmayer M, Mueller T, Lange W, Luft C, Hainzl A, Poelz W, Haidinger D. Relation between homocysteine and non-fatal stroke in peripheral arterial disease. Eur J Neurol. 2002 Nov;9(6):609-14.

Hamelahti P, Jarvinen O, Sisto T, Wirta V, Ilveskoski E, Koivula T, Lehtimaki T. Methylenetetrahydrofolate reductase gene C677T mutation is related to the defects in the internal elastic lamina of the artery wall. Eur J Clin Invest. 2002 Dec;32(12):869-73.

Handy DE, Loscalzo J. Homocysteine and atherothrombosis: diagnosis and treatment. Curr Atheroscler Rep. 2003 Jul;5(4):276-83.

Hankey GJ. Is homocysteine a causal and treatable risk factor for vascular diseases of the brain (cognitive impairment and stroke)? Ann Neurol. 2002 Mar;51(3):279-81. Review.

Hanratty CG, McGrath LT, McAuley DF, Young IS, Johnston GD. The effects of oral methionine and homocysteine on endothelial function. Heart. 2001 Mar;85(3):326-30.

Hansrani M, Stansby G. Homocysteine lowering interventions for peripheral arterial disease and bypass grafts. Cochrane Database Syst Rev. 2002;(3):CD003285. Review.

Hansrani M, Gillespie JI, Stansby G. Homocysteine in myointimal hyperplasia. Eur J Vasc Endovasc Surg. 2002 Jan;23(1):3-10. Review.

Haraki T, Takegoshi T, Kitoh C, Kajinami K, Wakasugi T, Hirai J, Shimada T, Kawashiri M, Inazu A, Koizumi J, Mabuchi H. Hyperhomocysteinemia, diabetes mellitus, and carotid atherosclerosis independently increase atherosclerotic vascular disease outcome in Japanese patients with end-stage renal disease. Clin Nephrol. 2001 Aug;56(2):132-9.

Hasty R, Smolar EN. Homocysteine. Compr Ther. 2002 Spring;28(1):34-8. Review.

Haynes WG. Hyperhomocysteinemia, vascular function and atherosclerosis: effects of vitamins. Cardiovasc Drugs Ther. 2002 Sep;16(5):391-9. Review.

Henning BF, Tepel M, Graefe U, Zidek W. [Homocysteine and its metabolites in chronic renal insufficiency and the effect of a vitamin replacement] Med Klin. 2000 Sep 15;95(9):477-81. German.

Henning BF, Zidek W, Riezler R, Graefe U, Tepel M. Homocyst(e)ine metabolism in hemodialysis patients treated with vitamins B6, B12 and folate. Res Exp Med (Berl). 2001 Mar;200(3):155-68.

Hernanz A, Fernandez-Vivancos E, Montiel C, Vazquez JJ, Arnalich F. Changes in the intracellular homocysteine and glutathione content associated with aging. Life Sci. 2000 Aug 4;67(11):1317-24.

Herrmann W, Knapp JP. Hyperhomocysteinemia: a new risk factor for degenerative diseases. Clin Lab. 2002;48(9-10):471-81. Review.

Hill CH, Mecham R, Starcher B. Fibrillin-2 defects impair elastic fiber assembly in a homocysteinemic chick model. J Nutr. 2002 Aug;132(8):2143-50. Erratum in: J Nutr 2002 Nov;132(11):3431.

Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM. The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int. 2002 Nov;62(5):1524-38. Review.

Hirose N, Arai Y, Ishii T, Tushima M, Li J. Association of mild hyperhomocysteinemia with aortic calcification in hypercholesterolemic patients. J Atheroscler Thromb. 2001;8(3):91-4.

Hirose N, Arai Y, Yamamura K, Nakazawa S, Takayama M, Ebihara Y, Homma S, Shimizu K. [Suggestions from a centenarian study--aging and inflammation] Nippon Ronen Igakkai Zasshi. 2001 Mar;38(2):121-4. Review. Japanese.

Hofmann MA, Lalla E, Lu Y, Gleason MR, Wolf BM, Tanji N, Ferran LJ Jr, Kohl B, Rao V, Kisiel W, Stern DM, Schmidt AM. Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model. J Clin Invest. 2001 Mar;107(6):675-83.

Hong MK, Park SW, Lee CW, Choi SW, Song JM, Kang DH, Song JK, Kim JJ, Park SJ. Elevated homocysteine levels might be associated with coronary artery remodeling in patients with stable angina: an intravascular ultrasound study. Clin Cardiol. 2002 May;25(5):225-9.

Horl WH. [In Process Citation] Wien Klin Wochenschr. 2003 Apr 30;115(7-8):220-34. German

Hossain GS, van Thienen JV, Werstuck GH, Zhou J, Sood SK, Dickhout JG, de Koning AB, Tang D, Wu D, Falk E, Poddar R, Jacobsen DW, Zhang K, Kaufman RJ, Austin RC. TDAG51 is induced by homocysteine, promotes detachment-mediated programmed cell death, and contributes to the cevelopment of atherosclerosis in hyperhomocysteinemia. J Biol Chem. 2003 Aug 8;278(32):30317-27. Epub 2003 May 08.

Huemer M, Fodinger M, Huemer C, Sailer-Hock M, Falger J, Rettenbacher A, Bernecker M, Artacker G, Kenzian H, Lang T, Stockler-Ipsiroglu S. Hyperhomocysteinemia in children with juvenile idiopathic arthritis is not influenced by methotrexate treatment and folic acid supplementation: a pilot study. Clin Exp Rheumatol. 2003 Mar-Apr;21(2):249-55.

Hultberg B, Isaksson A, Nilsson K, Gustafson L. [Homocysteine and methylmalonic acid as markers of cobalamin/folate status. The association to neuropsychiatric symptoms in the elderly is explored] Lakartidningen. 2000 Sep 20;97(38):4131-4, 4136. Review. Swedish.

Hunt ME, O'Malley PG, Vernalis MN, Feuerstein IM, Taylor AJ. C-reactive protein is not associated with the presence or extent of calcified subclinical atherosclerosis. Am Heart J. 2001 Feb;141(2):206-10.

Iacoviello L, Donati MB, de Gaetano G. [Novel risk factors for atherosclerosis. A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a) and cholesterol as predictors of peripheral arteriopathy] Ital Heart J. 2001 Sep;2(9 Suppl):1031-3. Italian.

Imai Y, Nagai R. [New biochemical and genetic risk factors for coronary artery diseases] Nippon Rinsho. 2003 Apr;61 Suppl 4:775-80. Review. Japanese.

200. Inamoto N, Katsuya T, Kokubo Y, Mannami T, Asai T, Baba S, Ogata J, Tomoike H, Ogihara T. Association of methylenetetrahydrofolate reductase gene polymorphism with carotid atherosclerosis depending on smoking status in a Japanese general population. Stroke. 2003 Jul;34(7):1628-33. Epub 2003 May 29.

Infante-Rivard C, Rivard GE, Gauthier R, Theoret Y. Unexpected Relationship between Plasma Homocysteine and Intrauterine Growth Restriction. Clin Chem. 2003 Sep;49(9):1476-1482.

Irvin-Jones A. Lowering plasma homocyst(e)ine may affect atherosclerotic disease. Nurse Pract. 2002 Oct;27(10):52-4.

Ishii H, Yoshida M, Hiraoka M, Hajjar KA, Tanaka A, Yasukochi Y, Numano F. Recombinant annexin II modulates impaired fibrinolytic activity in vitro and in rat carotid artery. Circ Res. 2001 Dec 7;89(12):1240-5.

Jakubowski H. Calcium-dependent human serum homocysteine thiolactone hydrolase. A protective mechanism against protein N-homocysteinylation. J Biol Chem. 2000 Feb 11;275(6):3957-62.

Jakubowski H. Translational incorporation of S-nitrosohomocysteine into protein. J Biol Chem. 2000 Jul 21;275(29):21813-6.

Jakubowski H, Zhang L, Bardeguez A, Aviv A. Homocysteine thiolactone and protein homocysteinylation in human endothelial cells: implications for atherosclerosis. Circ Res. 2000 Jul 7;87(1):45-51.

Jakubowski H, Ambrosius WT, Pratt JH. Genetic determinants of homocysteine thiolactonase activity in humans: implications for atherosclerosis. FEBS Lett. 2001 Feb 23;491(1-2):35-9.

Jakubowski H. Protein N-homocysteinylation: implications for atherosclerosis. Biomed Pharmacother. 2001 Oct;55(8):443-7. Review.

Jakubowski H. Translational accuracy of aminoacyl-tRNA synthetases: implications for atherosclerosis. J Nutr. 2001 Nov;131(11):2983S-7S. Review.

Jee SH, Song KS, Shim WH, Kim HK, Suh I, Park JY, Won SY, Beaty TH. Major gene evidence after MTHFR-segregation analysis of serum homocysteine in families of patients undergoing coronary arteriography. Hum Genet. 2002 Aug;111(2):128-35. Epub 2002 Jun 29.

Jensen OK, Rasmussen C, Mollerup F, Christensen PB, Hansen H, Ekelund S, Thulstrup AM. Hyperhomocysteinemia in rheumatoid arthritis: influence of methotrexate treatment and folic acid supplementation. J Rheumatol. 2002 Aug;29(8):1615-8.

Jermendy G, Hidvegi T, Hetyesi K. [Plasma homocysteine levels in hyperinsulinemic patients] Orv Hetil. 2001 Feb 11;142(6):277-81. Hungarian.

Johnson MA, Hawthorne NA, Brackett WR, Fischer JG, Gunter EW, Allen RH, Stabler SP. Hyperhomocysteinemia and vitamin B-12 deficiency in elderly using Title IIIc nutrition services. Am J Clin Nutr. 2003 Jan;77(1):211-20.

Joosten E. Homocysteine, vascular dementia and Alzheimer's disease. Clin Chem Lab Med. 2001 Aug;39(8):717-20. Review.

Kalmijn S, Launer LJ, Lindemans J, Bots ML, Hofman A, Breteler MM. Total homocysteine and cognitive decline in a community-based sample of elderly subjects: the Rotterdam Study. Am J Epidemiol. 1999 Aug 1;150(3):283-9.

Karabiber H, Sonmezgoz E, Ozerol E, Yakinci C, Otlu B, Yologlu S. Effects of valproate and carbamazepine on serum levels of homocysteine, vitamin B12, and folic acid. Brain Dev. 2003 Mar;25(2):113-5.

Karpati I, Balla J, Szoke G, Bereczky Z, Pall D, Ben T, Toma K, Katona E, Mohacsi A, Paragh G, Varga Z, Kakuk G, Muszbek L. [Frequency of hyperhomocysteinemia in hemodialysis patients with folic acid supplementation] Orv Hetil. 2002 Jul 7;143(27):1635-40. Hungarian.

Karthikeyan G, Prabhakaran D, Reddy KS. Plasma homocysteine levels and cardiovascular risk in Indians. J Assoc Physicians India. 2002 May;50 Suppl:24-8. Review.

Kawamoto R, Doi T, Tokunaga H. Association of plasma homocysteine concentrations with carotid atherosclerosis in elderly Japanese. Intern Med. 2001 Dec;40(12):1189-94.

Kawamoto R, Kohara K, Tabara Y, Miki T, Doi T, Tokunaga H, Konishi I. An association of 5,10-methylenetetrahydrofolate reductase (MTHFR) gene polymorphism and common carotid atherosclerosis. J Hum Genet. 2001;46(9):506-10.

Kawamoto R, Kajiwara T, Oka Y, Takagi Y. An association between plasma homocysteine concentrations and ischemic stroke in elderly Japanese. J Atheroscler Thromb. 2002;9(2):121-5.

Kelly PJ, Rosand J, Kistler JP, Shih VE, Silveira S, Plomaritoglou A, Furie KL. Homocysteine, MTHFR 677C-->T polymorphism, and risk of ischemic stroke: results of a meta-analysis. Neurology. 2002 Aug 27;59(4):529-36.

Kelly PJ, Furie KL. Management and Prevention of Stroke Associated with Elevated Homocysteine. Curr Treat Options Cardiovasc Med. 2002 Oct;4(5):363-371

Kelly PJ, Furie KL, Kistler JP, Barron M, Picard EH, Mandell R, Shih VE. Stroke in young patients with hyperhomocysteinemia due to cystathionine beta-synthase deficiency. Neurology. 2003 Jan 28;60(2):275-9.

Kennedy R, Case C, Fathi R, Johnson D, Isbel N, Marwick TH. Does renal failure cause an atherosclerotic milieu in patients with end-stage renal disease? Am J Med. 2001 Feb 15;110(3):198-204.

Kes P. Hyperhomocysteinemia in end-stage renal failure. Acta Med Croatica. 2000;54(4-5):175-81. Review.

Kessler H, Bleich S, Falkai P, Supprian T. [Homocysteine and dementia] Fortschr Neurol Psychiatr. 2003 Mar;71(3):150-6. Review. German.

Khajuria A, Houston DS. Induction of monocyte tissue factor expression by homocysteine: a possible mechanism for thrombosis. Blood. 2000 Aug 1;96(3):966-72.

Kielstein JT, Boger RH, Bode-Boger SM, Frolich JC, Haller H, Ritz E, Fliser D. Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renal disease. J Am Soc Nephrol. 2002 Jan;13(1):170-6.

Kimura H, Gejyo F, Suzuki S, Takeda T, Miyazaki R, Yoshida H. A C677T mutation in the methylenetetrahydrofolate reductase gene modifies serum cysteine in dialysis patients. Am J Kidney Dis. 2000 Nov;36(5):925-33.

Kimura H, Yoshida H. [New clinical laboratory tests for urinary tract diseases] Nippon Naika Gakkai Zasshi. 2001 Nov 10;90(11):2219-24. Review. Japanese. No abstract available.

Kimura H, Yoshida H. [Risk factors for atherosclerotic vascular disease in patients on maintenance hemodialysis--with especial respect to reverse cholesterol transport system and hyperhomocysteinemia] Rinsho Byori. 2002 Aug;50(8):793-801. Japanese.

Kircher T, Sinzinger H. Homocysteine--relevant for atherogenesis? Wien Klin Wochenschr. 2000 Jun 16;112(12):523-32. Review.

Kishi T, Tanaka Y, Ueda K. Evidence for hypomethylation in two children with acute lymphoblastic leukemia and leukoencephalopathy. Cancer. 2000 Aug 15;89(4):925-31.

Kitiyakara C, Gonin J, Massy Z, Wilcox CS. Non-traditional cardiovascular disease risk factors in end-stage renal disease: oxidate stress and hyperhomocysteinemia. Curr Opin Nephrol Hypertens. 2000 Sep;9(5):477-87. Review.

Kluijtmans LA, Whitehead AS. Methylenetetrahydrofolate reductase genotypes and predisposition to atherothrombotic disease; evidence that all three MTHFR C677T genotypes confer different levels of risk. Eur Heart J. 2001 Feb;22(4):294-9.

Knopman D, Patterson M. An open-label, 24-week pilot study of the methyl donor betaine in Alzheimer disease patients. Alzheimer Dis Assoc Disord. 2001 Jul-Sep;15(3):162-5.

Koga T, Claycombe K, Meydani M. Homocysteine increases monocyte and T-cell adhesion to human aortic endothelial cells. Atherosclerosis. 2002 Apr;161(2):365-74. Konstantinov VO. Nutrition and metabolism. Curr Opin Lipidol. 2001 Oct;12(5):579-81.

Konukoglu D, Serin O, Ercan M, Turhan MS. Plasma homocysteine levels in obese and non-obese subjects with or without hypertension; its relationship with oxidative stress and copper. Clin Biochem. 2003 Jul;36(5):405-8.

Korkmaz C, Bozan B, Kosar M, Sahin F, Gulbas Z. Is there an association of plasma homocysteine levels with vascular involvement in patients with Behcet's syndrome? Clin Exp Rheumatol. 2002 Jul-Aug;20(4 Suppl 26):S30-4.

Korkmaz ME, Atar I, Tayfun E, Yildirir A, Ulucam M, Ozin B, Muderrisoglu H, Turan M. Effects of a beta-blocker and spironolactone on plasma homocysteine levels. Int J Cardiol. 2003 Mar;88(1):119-20.

Kosokabe T, Okumura K, Sone T, Kondo J, Tsuboi H, Mukawa H, Tomida T, Suzuki T, Kamiya H, Matsui H, Hayakawa T. Relation of a common methylenetetrahydrofolate reductase mutation and plasma homocysteine with intimal hyperplasia after coronary stenting. Circulation. 2001 Apr 24;103(16):2048-54.

Kowalski M. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque. J Physiol Pharmacol. 2001 Aug;52(1 Suppl 1):3-31.

Koyama K, Usami T, Takeuchi O, Morozumi K, Kimura G. Efficacy of methylcobalamin on lowering total homocysteine plasma concentrations in haemodialysis patients receiving high-dose folic acid supplementation. Nephrol Dial Transplant. 2002 May;17(5):916-22. Krajcovicova-Kudlackova M, Blazicek P, Babinska K, Kopcova J, Klvanova J, Bederova A, Magalova T. Traditional and alternative nutrition--levels of homocysteine and lipid parameters in adults. Scand J Clin Lab Invest. 2000 Dec;60(8):657-64.

Krajcovicova-Kudlackova M, Ginter E, Blazicek P, Klvanova J. Homocysteine and vitamin C. Bratisl Lek Listy. 2002;103(4-5):171-3.

Krasniak A, Drozdz M, Chmiel G, Szumilak D, Kowalczyk-Michalek M, Podolec P, Pasowicz M, Klimeczek P, Konieczynska M, Wicher-Muniak E, Tracz W, Sulowicz W. [Evaluation of atherosclerosis progression in patients treated repeatedly with hemodialysis] Przegl Lek. 2002;59(8):606-10. Polish.

Krivonyak GS, Warren SG, Miller S. Hyperhomocysteinemia in West Virginians with documented atherosclerotic disease. W V Med J. 2001 Jul-Aug;97(4):201-4.

Krmar RT, Ferraris JR, Ramirez JA, Galarza CR, Waisman G, Janson JJ, Llapur CJ, Sorroche P, Legal S, Camera MI. Hyperhomocysteinemia in stable pediatric, adolescents, and young adult renal transplant recipients. Transplantation. 2001 Jun 27;71(12):1748-51.

Kroger K, Buss C, Renzing-Kohler K, Santosa F, Rudofsky G. Segmental manifestation of peripheral atherosclerosis and its association to risk factors. Vasa. 2000 Aug;29(3):199-203.

Kroger K, Buss C, Goyen M, Renzing-Kohler K, Rudofsky G. Risk factors in young patients with peripheral atherosclerosis. Int Angiol. 2000 Sep;19(3):206-11.

Kruman II, Culmsee C, Chan SL, Kruman Y, Guo Z, Penix L, Mattson MP. Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J Neurosci. 2000 Sep 15;20(18):6920-6.

Krumdieck CL, Prince CW. Mechanisms of homocysteine toxicity on connective tissues: implications for the morbidity of aging. J Nutr. 2000 Feb;130(2S Suppl):365S-368S. Review.

Krupkova-Meixnerova L, Vesela K, Vitova A, Janosikova B, Andel M, Kozich V. Methionine-loading test: evaluation of adverse effects and safety in an epidemiological study.Clin Nutr. 2002 Apr;21(2):151-6.

Kuan YM, E Dear A, Grigg MJ. Homocysteine: an aetiological contributor to peripheral vascular arterial disease. ANZ J Surg. 2002 Sep;72(9):668-71. Review.

Kullo IJ, Gau GT, Tajik AJ. Novel risk factors for atherosclerosis. Mayo Clin Proc. 2000 Apr;75(4):369-80. Review.

Kumagai H, Katoh S, Hirosawa K, Kimura M, Hishida A, Ikegaya N. Renal tubulointerstitial injury in weanling rats with hyperhomocysteinemia. Kidney Int. 2002 Oct;62(4):1219-28.

Kumar AV, Lokhandwala Y. Homocysteine--are we making a mountain out of a molehill? J Assoc Physicians India. 2002 Oct;50:1227-8.

Kundur RN, Flattery M, Hess M. Homocysteine/coronary atherosclerosis and cardiac transplantation:a case control study. J Heart Lung Transplant. 2001 Feb;20(2):196.

Laaksonen R, Janatuinen T, Vesalainen R, Lehtimaki T, Elovaara I, Jaakkola O, Jokela H, Laakso J, Nuutila P, Punnonen K, Raitakari O, Saikku P, Salminen K, Knuuti J. High oxidized LDL and elevated plasma homocysteine contribute to the early reduction of myocardial flow reserve in healthy adults. Eur J Clin Invest. 2002 Nov;32(11):795-802.

Landewe RB, van den Borne BE, Breedveld FC, Dijkmans BA. Methotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidity. Lancet. 2000 May 6;355(9215):1616-7.

Langman LJ, Ray JG, Evrovski J, Yeo E, Cole DE. Hyperhomocyst(e)inemia and the increased risk of venous thromboembolism: more evidence from a case-control study. Arch Intern Med. 2000 Apr 10;160(7):961-4.

Laskowska-Klita T. [Homocysteine and hyperhomocysteinemia] Pol Merkuriusz Lek. 2001 Mar;10(57):135-7. Polish.

Lazzerini PE, Capecchi PL, Bisogno S, Galeazzi M, Marcolongo R, Pasini FL. Reduction in plasma homocysteine level in patients with rheumatoid arthritis given pulsed glucocorticoid treatment. Ann Rheum Dis. 2003 Jul;62(7):694-5.

Leblhuber F, Walli J, Artner-Dworzak E, Vrecko K, Widner B, Reibnegger G, Fuchs D. Hyperhomocysteinemia in dementia. J Neural Transm. 2000;107(12):1469-74.

Lee KU. Oxidative stress markers in Korean subjects with insulin resistance syndrome. Diabetes Res Clin Pract. 2001 Dec;54 Suppl 2:S29-33. Review.

Lehmann M, Gottfries CG, Regland B. Identification of cognitive impairment in the elderly: homocysteine is an early marker. Dement Geriatr Cogn Disord. 1999 Jan-Feb;10(1):12-20.

Lehmann M, Regland B, Blennow K, Gottfries CG. Vitamin B12-B6-folate treatment improves blood-brain barrier function in patients with hyperhomocysteinaemia and mild cognitive impairment. Dement Geriatr Cogn Disord. 2003;16(3):145-50. Lentz SR, Piegors DJ, Malinow MR, Heistad DD. Supplementation of atherogenic diet with B vitamins does not prevent atherosclerosis or vascular dysfunction in monkeys. Circulation. 2001 Feb 20;103(7):1006-11.

Lentz SR. Does homocysteine promote atherosclerosis? Arterioscler Thromb Vasc Biol. 2001 Sep;21(9):1385-6.

Lentz SR, Miller FJ Jr, Piegors DJ, Erger RA, Fernandez JA, Griffin JH, Heistad DD. Anticoagulant responses to thrombin are enhanced during regression of atherosclerosis in monkeys. Circulation. 2002 Aug 13;106(7):842-6.

Leoncini G, Pascale R, Signorello MG. Effects of homocysteine on l-arginine transport and nitric oxide formation in human platelets. Eur J Clin Invest. 2003 Aug;33(8):713-9.

Levy HL, Vargas JE, Waisbren SE, Kurczynski TW, Roeder ER, Schwartz RS, Rosengren S, Prasad C, Greenberg CR, Gilfix BM, MacGregor D, Shih VE, Bao L, Kraus JP. Reproductive fitness in maternal homocystinuria due to cystathionine beta-synthase deficiency. J Inherit Metab Dis. 2002 Aug;25(4):299-314.

Li H, Goligorsky MS. Endothelial gene responses to homocysteine: relation to atherosclerosis. Exp Nephrol. 2002;10(2):164-9. Review.

Li H, Lewis A, Brodsky S, Rieger R, Iden C, Goligorsky MS. Homocysteine induces 3-hydroxy-3-methylglutaryl coenzyme a reductase in vascular endothelial cells: a mechanism for development of atherosclerosis? Circulation. 2002 Mar 5;105(9):1037-43.

Li J, Zhang Y, Yao X, Zhang B, Du J, Tang C. Effect of homocysteine on the L-arginine/nitric oxide synthase/nitric oxide pathway in human platelets. Heart Vessels. 2002 Jan;16(2):46-50. Liaugaudas G, Jacques PF, Selhub J, Rosenberg IH, Bostom AG. Renal insufficiency, vitamin B(12) status, and population attributable risk for mild hyperhomocysteinemia among coronary artery disease patients in the era of folic acid-fortified cereal grain flour. Arterioscler Thromb Vasc Biol. 2001 May;21(5):849-51.

Liem A, Reynierse-Buitenwerf GH, Zwinderman AH, Jukema JW, van Veldhuisen DJ. Secondary prevention with folic acid: effects on clinical outcomes. J Am Coll Cardiol. 2003 Jun 18;41(12):2105-13.

Lim PS, Hung WR, Wei YH. Polymorphism in methylenetetrahydrofolate reductase gene: its impact on plasma homocysteine levels and carotid atherosclerosis in ESRD patients receiving hemodialysis. Nephron. 2001 Mar;87(3):249-56.

Lindner A, Bankson DD, Stehman-Breen C, Mahuren JD, Coburn SP. Vitamin B6 metabolism and homocysteine in end-stage renal disease and chronic renal insufficiency. Am J Kidney Dis. 2002 Jan;39(1):134-45.

Linton MF, Fazio S; National Cholesterol Education Program (NCEP)- the third Adult Treatment Panel (ATP III). A practical approach to risk assessment to prevent coronary artery disease and its complications. Am J Cardiol. 2003 Jul 3;92(1A):19i-26i. Review.

Lochow P, Schwartzbard A, Guest J, Ripps C, Matalon D, Gambetta R, Tunick PA, Sedlis S. Elevated prothrombin and activated protein C resistance in patients with thoracic aortic atheroma. Angiology. 2002 Jul-Aug;53(4):423-8.

Locsey L, Szegedi J, Dan A, Gorogh S, Toths E. Homocysteine and cystatin C level changes in haemodialysed patients and connection with cerebro- and cardiovascular complications. Acta Physiol Hung. 2001;88(3-4):293-9.

Logar CM, Herzog CA, Beddhu S. Diagnosis and therapy of coronary artery disease in renal failure, end-stage renal disease, and renal transplant populations. Am J Med Sci. 2003 Apr;325(4):214-27. Review.

Lokk J. News and views on folate and elderly persons. J Gerontol A Biol Sci Med Sci. 2003 Apr;58(4):354-61. Review.

Loncar R, Hrboka V, Tabakovic-Loncar V, Ostojic Z, Deussen A. Screening of plasma homocysteine in peripheral arterial disease. Ann Med. 2001 Feb;33(1):48-54.

Lopez Ridaura R. [Homocysteine and atherosclerosis. The controlled clinical trials phase that people have been waiting for so long. Can multivitamins reduce coronary disease?] Rev Invest Clin. 2000 May-Jun;52(3):223-6. Spanish.

Loscalzo J. Key references: Homocysteine and atherothrombotic vascular disease. J Thromb Thrombolysis. 2000 Jan;9(1):125-6.

Loscalzo J. Adverse effects of supplemental L-arginine in atherosclerosis: consequences of methylation stress in a complex catabolism? Arterioscler Thromb Vasc Biol. 2003 Jan 1;23(1):3-5.

Loverro G, Lorusso F, Mei L, Depalo R, Cormio G, Selvaggi L. The plasma homocysteine levels are increased in polycystic ovary syndrome. Gynecol Obstet Invest. 2002;53(3):157-62.

Luis AS. [Homocysteine] Rev Port Cardiol. 2001 May;20 Suppl 5:V-185-7. Portuguese.

Lynch SM, Campione AL, Moore MK. Plasma thiols inhibit hemin-dependent oxidation of human low-density lipoprotein. Biochim Biophys Acta. 2000 May 6;1485(1):11-22.

Machado DJ, Paula FJ, Sabbaga E, Ianhez LE. Hyperhomocyst(e)inemia in chronic stable renal transplant patients. Rev Hosp Clin Fac Med Sao Paulo. 2000 Sep-Oct;55(5):161-8.

Macy PA. Homocysteine: predictor of thrombotic disease. Clin Lab Sci. 2001 Fall;14(4):272-5.

Maeda N, Sawayama Y, Tatsukawa M, Okada K, Furusyo N, Shigematsu M, Kashiwagi S, Hayashi J. Carotid artery lesions and atherosclerotic risk factors in Japanese hemodialysis patients. Atherosclerosis. 2003 Jul;169(1):183-92.

Magyar MT, Szikszai Z, Balla J, Valikovics A, Kappelmayer J, Imre S, Balla G, Jeney V, Csiba L, Bereczki D. Early-onset carotid atherosclerosis is associated with increased intima-media thickness and elevated serum levels of inflammatory markers. Stroke. 2003 Jan;34(1):58-63.

Mahanonda N, Leowattana W, Kangkagate C, Lolekha P, Pokum S. Homocysteine and restenosis after percutaneous coronary intervention. J Med Assoc Thai. 2001 Dec;84 Suppl 3:S636-44.

Majors AK, Sengupta S, Jacobsen DW, Pyeritz RE. Upregulation of smooth muscle cell collagen production by homocysteine-insight into the pathogenesis of homocystinuria. Mol Genet Metab. 2002 Jun;76(2):92-9

300. Majors AK, Sengupta S, Willard B, Kinter MT, Pyeritz RE, Jacobsen DW. Homocysteine binds to human plasma fibronectin and inhibits its interaction with fibrin. Arterioscler Thromb Vasc Biol. 2002 Aug 1;22(8):1354-9.

Mancini M, Rubba P. [Ischemic cardiopathy: risk factors and their biological role] Ital Heart J. 2000 Jun;1 Suppl 2:17-22. Review. Italian.

Mansoor MA, Bergmark C, Haswell SJ, Savage IF, Evans PH, Berge RK, Svardal AM, Kristensen O. Correlation between plasma total homocysteine and copper in patients with peripheral vascular disease. Clin Chem. 2000 Mar;46(3):385-91. Erratum in: Clin Chem 2001 Aug;47(8):1505.

Marcucci R, Zanazzi M, Bertoni E, Rosati A, Fedi S, Lenti M, Prisco D, Castellani S, Abbate R, Salvadori M. Vitamin supplementation reduces the progression of atherosclerosis in hyperhomocysteinemic renal-transplant recipients. Transplantation. 2003 May 15;75(9):1551-5.

Mark L, Erdei F, Markizay J, Kondacs A, Katona A. Effect of treatment with folic acid and vitamin B6 on lipid and homocysteine concentrations in patients with coronary artery disease. Nutrition. 2002 May;18(5):428-9.

Martinez-Taboada VM, Bartolome MJ, Fernandez-Gonzalez MD, Blanco R, Rodriguez-Valverde V, Lopez-Hoyos M. Homocysteine levels in polymyalgia rheumatica and giant cell arteritis: influence of corticosteroid therapy. Rheumatology (Oxford). 2003 Sep;42(9):1055-61. Epub 2003 Apr 16.

Martinez Valverde A. [Effects of childhood nutrition on adult health] Allergol Immunopathol (Madr). 2003 May-Jun;31(3):166-72. Review. Spanish.

Massy ZA. Importance of homocysteine, lipoprotein (a) and non-classical cardiovascular risk factors (fibrinogen and advanced glycation end-products) for atherogenesis in uraemic patients. Nephrol Dial Transplant. 2000;15 Suppl 5:81-91. Review.

Massy ZA, Ceballos I, Chadefaux-Vekemens B, Nguyen-Khoa T, Descamps-Latscha B, Drueke TB, Jungers P. Homocyst(e)ine, oxidative stress, and endothelium function in uremic patients. Kidney Int Suppl. 2001 Feb;78:S243-5. Review.

Matsui T, Arai H, Yuzuriha T, Yao H, Miura M, Hashimoto S, Higuchi S, Matsushita S, Morikawa M, Kato A, Sasaki H. Elevated plasma homocysteine levels and risk of silent brain infarction in elderly people. Stroke. 2001 May;32(5):1116-9.

Mayer O, Filipovsky J, Hromadka M, Svobodova V, Racek J, Mayer O Jr, Stehlik P, Trefil L, Zarybnicka M. Treatment of hyperhomocysteinemia with folic acid: effects on homocysteine levels, coagulation status, and oxidative stress markers. J Cardiovasc Pharmacol. 2002 Jun;39(6):851-7.

McCaddon A, Davies G, Hudson P, Tandy S, Cattell H. Total serum homocysteine in senile dementia of Alzheimer type. Int J Geriatr Psychiatry. 1998 Apr;13(4):235-9.

McCaddon A, Hudson P, Davies G, Hughes A, Williams JH, Wilkinson C. Homocysteine and cognitive decline in healthy elderly. Demen Geriatr Cogn Disord. 2001 Sep-Oct;12(5):309-13.

McCaddon A, Hudson P, Hill D, Barber J, Lloyd A, Davies G, Regland B. Alzheimer's disease and total plasma aminothiols. Biol Psychiatry. 2003 Feb 1;53(3):254-60.

McGregor D, Shand B, Lynn K. A controlled trial of the effect of folate supplements on homocysteine, lipids and hemorheology in end-stage renal disease. Nephron. 2000 Jul;85(3):215-20.

McGregor DO, Dellow WJ, Lever M, George PM, Robson RA, Chambers ST. Dimethylglycine accumulates in uremia and predicts elevated plasma homocysteine concentrations. Kidney Int. 2001 Jun;59(6):2267-72.

McGregor DO, Buttimore AL, Lynn KL, Yandle T, Nicholls MG. Effects of long and short hemodialysis on endothelial function: a short-term study. Kidney Int. 2003 Feb;63(2):709-15.

McIlroy SP, Dynan KB, Lawson JT, Patterson CC, Passmore AP. Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland. Stroke. 2002 Oct;33(10):2351-6.

McKinley MC. Nutritional aspects and possible pathological mechanisms of hyperhomocysteinaemia: an independent risk factor for vascular disease. Proc Nutr Soc. 2000 May;59(2):221-37. Review.

Meiklejohn DJ, Vickers MA, Dijkhuisen R, Greaves M. Plasma homocysteine concentrations in the acute and convalescent periods of atherothrombotic stroke. Stroke. 2001 Jan;32(1):57-62.

Meissner T. [Hyperhomocysteinemia hastens myocardial infarct and stroke. Prevention.with leaf salads and vitamins] MMW Fortschr Med. 2003 Mar 6;145(10):10. German.

Melenovsky V, Stulc T, Kozich V, Grauova B, Krijt J, Wichterle D, Haas T, Malik J, Hradec J, Ceska R. Effect of folic acid on fenofibrate-induced elevation of homocysteine and cysteine. Am Heart J. 2003 Jul;146(1):110.

Mendis S, Ranatunga P, Jayatilake M, Wanninayake S, Wickremasinghe R. Hyperhomocysteinaemia in Sri Lankan patients with coronary artery disease. Ceylon Med J. 2002 Sep;47(3):89-92.

Merki-Feld GS, Imthurn B, Keller PJ. Effects of two oral contraceptives on plasma levels of nitric oxide, homocysteine, and lipid metabolism. Metabolism. 2002 Sep;51(9):1216-21.

Midorikawa S, Sanada H, Hashimoto S, Watanabe T. Enhancement by homocysteine of plasminogen activator inhibitor-1 gene expression and secretion from vascular endothelial and smooth muscle cells. Biochem Biophys Res Commun. 2000 May 27;272(1):182-5.

Milionis HJ, Winder AF, Mikhailidis DP. Lipoprotein (a) and stroke. J Clin Pathol. 2000 Jul;53(7):487-96. Review

Miller AL. The methionine-homocysteine cycle and its effects on cognitive diseases. Altern Med Rev. 2003 Feb;8(1):7-19. Review.

Miller JW. Homocysteine and Alzheimer's disease. Nutr Rev. 1999 Apr;57(4):126-9. Review.

Miller JW. Homocysteine, Alzheimer's disease, and cognitive function. Nutrition. 2000 Jul-Aug;16(7-8):675-7. Review.

Miller JW, Green R, Ramos MI, Allen LH, Mungas DM, Jagust WJ, Haan MN. Homocysteine and cognitive function in the Sacramento Area Latino Study on Aging. Am J Clin Nutr. 2003 Sep;78(3):441-7.

Mills BJ, Weiss MM, Lang CA, Liu MC, Ziegler C. Blood glutathione and cysteine changes in cardiovascular disease. J Lab Clin Med. 2000 May;135(5):396-401.

Milosevic-Tosic M, Borota J. [Hyperhomocysteinemia--a risk factor for development of occlusive vascular diseases] Med Pregl. 2002 Sep-Oct;55(9-10):385-91. Review. Serbo-Croatian (Roman).

Misra A. Risk factors for atherosclerosis in young individuals. J Cardiovasc Risk. 2000 Jun;7(3):215-29. Review

Mizrahi EH, Jacobsen DW, Debanne SM, Traore F, Lerner AJ, Friedland RP, Petot GJ. Plasma Total Homocysteine Levels, Dietary Vitamin B6 and Folate Intake In AD and Healthy Aging. J Nutr Health Aging. 2003;7(3):160-5.

Moghadasian MH, McManus BM, Nguyen LB, Shefer S, Nadji M, Godin DV, Green TJ, Hill J, Yang Y, Scudamore CH, Frohlich JJ. Pathophysiology of apolipoprotein E deficiency in mice: relevance to apo E-related disorders in humans. FASEB J. 2001 Dec;15(14):2623-30.

Morales JM, Gonzalez Molina M, Campistol JM, del Castillo D, Anaya F, Oppenheimer F, Gil Vernet JM, Grinyo JM, Capdevila L, Lampreave I, Valdes F, Marcen R, Escuin F, Andres A, Arias M, Pallardo L. [Prevention of cardiovascular risk in renal transplantation. Consensus document] Nefrologia. 2002;22 Suppl 4:35-56. Review. Spanish.

Morita H, Kurihara H, Yoshida S, Saito Y, Shindo T, Oh-Hashi Y, Kurihara Y, Yazaki Y, Nagai R. Diet-induced hyperhomocysteinemia exacerbates neointima formation in rat carotid arteries after balloon injury. Circulation. 2001 Jan 2;103(1):133-9.

Moriyama Y, Okamura T, Kajinami K, Iso H, Inazu A, Kawashiri M, Mizuno M, Takeda Y, Sakamoto Y, Kimura H, Suzuki H, Mabuchi H. Effects of serum B vitamins on elevated plasma homocysteine levels associated with the mutation of methylenetetrahydrofolate reductase gene in Japanese. Atherosclerosis. 2002 Oct;164(2):321-8.

Morris MS, Jacques PF, Rosenberg IH, Selhub J; National Health and Nutrition Examination Survey. Hyperhomocysteinemia associated with poor recall in the third National Health and Nutrition Examination Survey. Am J Clin Nutr. 2001 May;73(5):927-33.

Morris MS. Folate, homocysteine, and neurological function. Nutr Clin Care. 2002 May-Jun;5(3):124-32.

Moustapha A, Robinson K. Homocysteine: an emerging age-related cardiovascular risk factor. Geriatrics. 1999 Apr;54(4):41, 44-6, 49-51.

Mraovic T, Radakovic S, Pavlica M. [Effect of coffee drinking on the cardiovascular system] Vojnosanit Pregl. 2003 Jan-Feb;60(1):77-9. Serbo-Croatian (Roman).

Muller T. Non-dopaminergic drug treatment of Parkinson's disease. Expert Opin Pharmacother. 2001 Apr;2(4):557-72. Review.

Nagase M, Ando K, Nagase T, Kaname S, Sawamura T, Fujita T. Redox-sensitive regulation of lox-1 gene expression in vascular endothelium. Biochem Biophys Res Commun. 2001 Mar 2;281(3):720-5.

Naismith S, Hickie I, Ward PB, Turner K, Scott E, Little C, Mitchell P, Wilhelm K, Parker G. Caudate nucleus volumes and genetic determinants of homocysteine metabolism in the prediction of psychomotor speed in older persons with depression. Am J Psychiatry. 2002 Dec;159(12):2096-8.

Nakanishi T, Hasuike Y, Otaki Y, Hama Y, Nanami M, Miyagawa K, Moriguchi R, Nishikage H, Izumi M, Takamitsu Y. Free cysteine is increased in plasma from hemodialysis patients. Kidney Int. 2003 Mar;63(3):1137-40.

Nakaso K, Yasui K, Kowa H, Kusumi M, Ueda K, Yoshimoto Y, Takeshima T, Sasaki K, Nakashima K. Hypertrophy of IMC of carotid artery in Parkinson's disease is associated with L-DOPA, homocysteine, and MTHFR genotype. J Neurol Sci. 2003 Mar 15;207(1-2):19-23.

Narin F, Narin N, Akcakus M, Ustdal M, Karakucuk I, Halici C. The effect of folic acid, vitamin B6 and vitamin B12 on the homocysteine levels in rabbits fed by methionine-enriched diets. Tohoku J Exp Med. 2002 Oct;198(2):99-105.

Naruszewicz M. [Homocysteine: a risk factor for atherosclerosis] Neurol Neurochir Pol. 2000 Jul-Aug;34(4):637-43. Polish.

Naurath HJ. Hyperhomocysteinemia in advanced age. Clin Chem Lab Med. 2001 Aug;39(8):695-7.

Nestel P. Biomarkers, surrogates for nutritional evidence. Curr Opin Lipidol. 2002 Feb;13(1):1-2.

Neugroschl J, Davis KL. Biological markers in Alzheimer disease. Am J Geriatr Psychiatry. 2002 Nov-Dec;10(6):660-77. Review

Ngeh J, Anand V, Gupta S. Chlamydia pneumoniae and atherosclerosis -- what we know and what we don't. Clin Microbiol Infect. 2002 Jan;8(1):2-13. Review.

Nielsen NE, Brattstrom L, Hultberg B, Landgren F, Swahn E. Plasma total homocysteine levels in postmenopausal women with unstable coronary artery disease.. Atherosclerosis. 2000 Aug;151(2):423-31.

Nikfardjam M, Graf S, Hornykewycz S, Zorn G, Huber-Beckmann R, Wojta J, Huber K. Homocysteine plasma levels in young patients with coronary artery disease. Relation to history of acute myocardial infarction and anatomical extent of disease. Thromb Res. 2001 Sep 30;103 Suppl 1:S35-9.

Nilsson K, Gustafson L, Hultberg B. The plasma homocysteine concentration is better than that of serum methylmalonic acid as a marker for sociopsychological performance in a psychogeriatric population. Clin Chem. 2000 May;46(5):691-6.

Nilsson K, Warkentin S, Hultberg B, Faldt R, Gustafson L. Treatment of cobalamin deficiency in dementia, evaluated clinically and with cerebral blood flow measurements. Aging (Milano). 2000 Jun;12(3):199-207.

Nilsson K, Gustafson L, Hultberg B. Improvement of cognitive functions after cobalamin/folate supplementation in elderly patients with dementia and elevated plasma homocysteine. Int J Geriatr Psychiatry. 2001 Jun;16(6):609-14.

Nishizawa Y, Shoji T, Ishimura E, Inaba M, Morii H. Paradox of risk factors for cardiovascular mortality in uremia: is a higher cholesterol level better for atherosclerosis in uremia? Am J Kidney Dis. 2001 Oct;38(4 Suppl 1):S4-7.

Nonaka H, Tsujino T, Watari Y, Emoto N, Yokoyama M. Taurine prevents the decrease in expression and secretion of extracellular superoxide dismutase induced by homocysteine: amelioration of homocysteine-induced endoplasmic reticulum stress by taurine. Circulation. 2001 Sep 4;104(10):1165-70.

Nourhashemi F, Gillette-Guyonnet S, Andrieu S, Ghisolfi A, Ousset PJ, Grandjean H, Grand A, Pous J, Vellas B, Albarede JL. Alzheimer disease: protective factors. Am J Clin Nutr. 2000 Feb;71(2):643S-649S. Review.

Nurk E, Tell GS, Nygard O, Refsum H, Ueland PM, Vollset SE. Plasma total homocysteine is influenced by prandial status in humans: the Hordaland Hhomocysteine Sstudy. J Nutr. 2001 Apr;131(4):1214-6.

O'Grady H, Kelly C, Bouchier-Hayes D, Leahy A. Homocysteine and occlusive arterial disease. Br J Surg. 2002 Jul;89(7):838-44. Review. Oh R, Brown DL. Vitamin B12 deficiency. Am Fam Physician. 2003 Mar 1;67(5):979-86. Review. Summary for patients in: Am Fam Physician. 2003 Mar 1;67(5):993-4.

Ohkuma T, Minagawa T, Takada N, Ohno M, Oda H, Ohashi H. C-reactive protein, lipoprotein(a), homocysteine, and male sex contribute to carotid atherosclerosis in peritoneal dialysis patients. Am J Kidney Dis. 2003 Aug;42(2):355-61.

Oishi K, Nagake Y, Yamasaki H, Fukuda S, Ichikawa H, Ota K, Makino H. The significance of serum homocysteine levels in diabetic patients on haemodialysis. Nephrol Dial Transplant. 2000 Jun;15(6):851-5.

Olivieri O, Friso S, Trabetti E, Girelli D, Pizzolo F, Faccini G, Stranieri C, Pignatti PF, Corrocher R. Homocysteine and atheromatous renal artery stenosis. Clin Exp Med. 2001 Dec;1(4):211-8.

Opatrny K Jr, Zemanova P, Mares J, Vit L, Opatrna S, Sefrna F, Hejda V, Tomsu M, Eiselt J, Massry SG. Fibrinolysis defect in long-term hemodialysis patients with type 2 diabetes mellitus and its relation to metabolic disorders. Am J Nephrol. 2002 Sep-Dec;22(5-6):429-36.

Os I, Os A, Sandset PM, Bolling S, Seljeflot I, Djurovic S, Westheim A. Hormone replacement therapy does not affect plasma homocysteine in postmenopausal women with coronary artery disease. Free tissue factor pathway inhibitor antigen, a circulating anticoagulant, is related to plasma homocysteine. Cardiology. 2002;98(1-2):6-12.

Ovuworie CA, Fox ER, Chow CM, Pascual M, Shih VE, Picard MH, Tolkoff-Rubin NE. Vascular endothelial function in cyclosporine and tacrolimus treated renal transplant recipients. Transplantation. 2001 Oct 27;72(8):1385-8.

Parhofer KG. [Homocysteine--CRP--lipoprotein (a). When do you evaluate the "new" risk factors] MMW Fortschr Med. 2001 Jan 25;143(4):22-4. German.

Park JS, Jung HH, Yang WS, Kim SB, Min WK, Chi HS. Effects of hormonal replacement therapy on lipid and haemostatic factors in post-menopausal ESRD patients. Nephrol Dial Transplant. 2000 Nov;15(11):1835-40.

Pasterkamp G, Algra A, Grobbee DE, de Jaegere PP, Banga JD, van der Graaf Y. Homocysteine and the stage of atherosclerotic disease: a study in patients suffering from clinically silent and clinically manifest atherosclerotic disease. Eur J Clin Invest. 2002 May;32(5):309-15.

Patrick L, Uzick M. Cardiovascular disease: C-reactive protein and the inflammatory disease paradigm: HMG-CoA reductase inhibitors, alpha-tocopherol, red yeast rice, and olive oil polyphenols. A review of the literature. Altern Med Rev. 2001 Jun;6(3):248-71. Review.

Pincemail J, Siquet J, Chapelle JP, Cheramy-Bien JP, Paulissen G, Chantillon AM, Christiaens G, Gielen J, Limet R, Defraigne JO. [Determination of plasma concentrations of antioxidants, antibodies against oxidized LDL, and homocysteine in a population sample from Liege] Ann Biol Clin (Paris). 2000 Mar-Apr;58(2):177-85. French.

Pines A, Bornstein NM, Shapira I. Menopause and ischaemic stroke: basic, clinical and epidemiological considerations. The role of hormone replacement. Hum Reprod Update. 2002 Mar-Apr;8(2):161-8. Review.

Pinn G. Herbs and metabolic/endocrine disease. From past to present. Aust Fam Physician. 2001 Feb;30(2):146-50.

Poirier LA. The effects of diet, genetics and chemicals on toxicity and aberrant DNA methylation: an introduction. J Nutr. 2002 Aug;132(8 Suppl):2336S-2339S. Pollak RD, Pollak A, Idelson M, Bejarano-Achache I, Doron D, Blumenfeld A. The C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene and vascular dementia. J Am Geriatr Soc. 2000 Jun;48(6):664-8.

Polyak Z, Stern F, Berner YN, Sela BA, Gomori JM, Isayev M, Doolman R, Levy S, Dror Y. Hyperhomocysteinemia and vitamin score: correlations with silent brain ischemic lesions and brain atrophy. Dement Geriatr Cogn Disord. 2003;16(1):39-45.

Prichard S. Risk factors for coronary artery disease in patients with renal failure. Am J Med Sci. 2003 Apr;325(4):209-13. Review.

Prins ND, Den Heijer T, Hofman A, Koudstaal PJ, Jolles J, Clarke R, Breteler MM; Rotterdam Scan Study. Homocysteine and cognitive function in the elderly: the Rotterdam Scan Study. Neurology. 2002 Nov 12;59(9):1375-80.

Quiroga I, Morris-Stiff G, Baboo R, Darby CR, Lord RH, Jurewicz WA. Differential homocysteine levels in renal transplant patients receiving neoral versus tacrolimus. Transplant Proc. 2001 Feb-Mar;33(1-2):1209-10.

Racek J, Rackova M. [Less common risk factors for atherogenesis--homocysteine, lipoprotein (a) and C-reactive protein] Cas Lek Cesk. 2002 Sep;141(19):605-9. Review. Czech.

Raghuveer G, Sinkey CA, Chenard C, Stumbo P, Haynes WG. Effect of vitamin E on resistance vessel endothelial dysfunction induced by methionine. Am J Cardiol. 2001 Aug 1;88(3):285-90.

Rampersaud GC, Kauwell GP, Bailey LB. Folate: a key to optimizing health and reducing disease risk in the elderly. J Am Coll Nutr. 2003 Feb;22(1):1-8.

Randeva HS, Lewandowski KC, Drzewoski J, Brooke-Wavell K, O'Callaghan C, Czupryniak L, Hillhouse EW, Prelevic GM. Exercise decreases plasma total homocysteine in overweight young women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2002 Oct;87(10):4496-501.

Raslova K, Smolkova B, Vohnout B, Gasparovic J, Frohlich JJ. Risk factors for atherosclerosis in survivors of myocardial infarction and their spouses: comparison to controls without personal and family history of atherosclerosis. Metabolism. 2001 Jan;50(1):24-9.

Rassoul F, Richter V, Janke C, Purschwitz K, Klotzer B, Geisel J, Herrmann W. Plasma homocysteine and lipoprotein profile in patients with peripheral arterial occlusive disease. Angiology. 2000 Mar;51(3):189-96.

Ravaglia G, Forti P, Maioli F, Muscari A, Sacchetti L, Arnone G, Nativio V, Talerico T, Mariani E. Homocysteine and cognitive function in healthy elderly community dwellers in Italy. Am J Clin Nutr. 2003 Mar;77(3):668-73.

Ravaglia G, Forti P, Maioli F, Zanardi V, Dalmonte E, Grossi G, Cucinotta D, Macini P, Caldarera M. Blood homocysteine and vitamin B levels are not associated with cognitive skills in healthy normally ageing subjects. J Nutr Health Aging. 2000;4(4):218-22.

Ravaglia G, Forti P, Maioli F, Vettori C, Grossi G, Bargossi AM, Caldarera M, Franceschi C, Facchini A, Mariani E, Cavalli G. Elevated plasma homocysteine levels in centenarians are not associated with cognitive impairment. Mech Ageing Dev. 2000 Dec 20;121(1-3):251-61.

Regensteiner JG, Hiatt WR. Current medical therapies for patients with peripheral arterial disease: a critical review. Am J Med. 2002 Jan;112(1):49-57. Review.

Reis SE, Olson MB, Fried L, Reeser V, Mankad S, Pepine CJ, Kerensky R, Merz CN, Sharaf BL, Sopko G, Rogers WJ, Holubkov R. Mild renal insufficiency is associated with angiographic coronary artery disease in women. Circulation. 2002 Jun 18;105(24):2826-9.

Reitman A, Friedrich I, Ben-Amotz A, Levy Y. Low plasma antioxidants and normal plasma B vitamins and homocysteine in patients with severe obesity. Isr Med Assoc J. 2002 Aug;4(8):590-3.

Religa D, Styczynska M, Peplonska B, Gabryelewicz T, Pfeffer A, Chodakowska M, Luczywek E, Wasiak B, Stepien K, Golebiowski M, Winblad B, Barcikowska M. Homocysteine, apolipoproteine E and methylenetetrahydrofolate reductase in Alzheimer's disease and mild cognitive impairment.Dement Geriatr Cogn Disord. 2003;16(2):64-70.

Reutens S, Sachdev P. Homocysteine in neuropsychiatric disorders of the elderly. Int J Geriatr Psychiatry. 2002 Sep;17(9):859-64.

Ridker PM, Shih J, Cook TJ, Clearfield M, Downs JR, Pradhan AD, Weis SE, Gotto AM Jr; Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) Investigators. Plasma homocysteine concentration, statin therapy, and the risk of first acute coronary events. Circulation. 2002 Apr 16;105(15):1776-9.

400. Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA. 2001 May 16;285(19):2481-5.

Riggs KM, Spiro A 3rd, Tucker K, Rush D. Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study. Am J Clin Nutr. 1996 Mar;63(3):306-14.

Robert K, Chasse JF, Santiard-Baron D, Vayssettes C, Chabli A, Aupetit J, Maeda N, Kamoun P, London J, Janel N. Altered Gene Expression in Liver from a Murine Model of Hyperhomocysteinemia. J Biol Chem. 2003 Aug 22;278(34):31504-31511. Epub 2003 Jun 10.

Robert K, Vialard F, Thiery E, Toyama K, Sinet PM, Janel N, London J. Expression of the cystathionine beta synthase (CBS) gene during mouse development and immunolocalization in adult brain. J Histochem Cytochem. 2003 Mar;51(3):363-71.

Rodriguez G, Sulli A, Cutolo M, Vitali P, Nobili F. Carotid atherosclerosis in patients with rheumatoid arthritis: a preliminary case-control study. Ann N Y Acad Sci. 2002 Jun;966:478-82.

Rodriguez-Nieto S, Chavarria T, Martinez-Poveda B, Sanchez-Jimenez F, Rodriguez Quesada A, Medina MA. Anti-angiogenic effects of homocysteine on cultured endothelial cells. Biochem Biophys Res Commun. 2002 Apr 26;293(1):497-500.

Rogers JD, Sanchez-Saffon A, Frol AB, Diaz-Arrastia R. Elevated plasma homocysteine levels in patients treated with levodopa: association with vascular disease. Arch Neurol. 2003 Jan;60(1):59-64.

Rubba P. Anti-inflammatory action of statins and reduction of homocysteinemia by vitamin supplementation: interactions among strategies for cardiovascular prevention. Nutr Metab Cardiovasc Dis. 2000 Aug;10(4):173-6. Review.

Sachdev PS, Valenzuela MJ, Brodaty H, Wang XL, Looi J, Lorentz L, Howard L, Jones M, Zagami AS, Gillies D, Wilcken DE. Homocysteine as a risk factor for cognitive impairment in stroke patients. Dement Geriatr Cogn Disord. 2003;15(3):155-62.

Saitta A, Morabito N, Frisina N, Cucinotte D, Corrado F, D'Anna R, Altavilla D, Squadrito G, Minutoli L, Arcoraci V, Cancellieri F, Squadrito F. Cardiovascular effects of raloxifene hydrochloride. Cardiovasc Drug Rev. 2001 Spring;19(1):57-74. Review.

Sanchez-Margalet V, Valle M, Ruz FJ, Gascon F, Mateo J, Goberna R. Elevated plasma total homocysteine levels in hyperinsulinemic obese subjects. J Nutr Biochem. 2002 Feb;13(2):75-79.

Sarnak MJ, Wang SR, Beck GJ, Kusek JW, Selhub J, Greene T, Levey AS. Homocysteine, cysteine, and B vitamins as predictors of kidney disease progression. Am J Kidney Dis. 2002 Nov;40(5):932-9.

Sarzi-Puttini P, Atzeni F, Carrabba M. [Cardiovascular risk factors in systemic lupus erythematosus and in antiphospholipid syndrome] Minerva Med. 2003 Apr;94(2):63-70. Review. Italian.

Sasaki S, Kuwahara N, Kunitomo K, Harada S, Yamada T, Azuma A, Takeda K, Nakagawa M. Effects of atorvastatin on oxidized low-density lipoprotein, low-density lipoprotein subfraction distribution, and remnant lipoprotein in patients with mixed hyperlipoproteinemia. Am J Cardiol. 2002 Feb 15;89(4):386-9.

Sasaki T, Watanabe M, Nagai Y, Hoshi T, Takasawa M, Nukata M, Taguchi A, Kitagawa K, Kinoshita N, Matsumoto M. Association of plasma homocysteine concentration with atherosclerotic carotid plaques and lacunar infarction. Stroke. 2002 Jun;33(6):1493-6.

Saso Y, Conner EM, Teegarden BR, Yuan CS. S-Adenosyl-L-homocysteine hydrolase inhibitor mediates immunosuppressive effects in vivo: suppression of delayed type hypersensitivity ear swelling and peptidoglycan polysaccharide-induced arthritis. J Pharmacol Exp Ther. 2001 Jan;296(1):106-12.

Sastry BK, Indira N, Anand B, Kedarnath, Prabha BS, Raju BS. A case-control study of plasma homocysteine levels in South Indians with and without coronary artery disease. Indian Heart J. 2001 Nov-Dec;53(6):749-53.

Sauls DL, Wolberg AS, Hoffman M. Elevated plasma homocysteine leads to alterations in fibrin clot structure and stability: implications for the mechanism of thrombosis in hyperhomocysteinemia. J Thromb Haemost. 2003 Feb;1(2):300-6.

Schalinske KL. Interrelationship between diabetes and homocysteine metabolism: hormonal regulation of cystathionine beta-synthase. Nutr Rev. 2003 Apr;61(4):136-8.

Scheuner MT. Genetic predisposition to coronary artery disease. Curr Opin Cardiol. 2001 Jul;16(4):251-60. Review.

Schreiner PJ, Wu KK, Malinow MR, Stinson VL, Szklo M, Nieto FJ, Heiss G. Hyperhomocyst(e)inemia and hemostatic factors: the atherosclerosis risk in communities study. Ann Epidemiol. 2002 May;12(4):228-36.

Schulpis KH, Karikas GA, Papakonstantinou E. Homocysteine and other vascular risk factors in patients with phenylketonuria on a diet. Acta Paediatr. 2002;91(8):905-9.

Schulthess G, Wiesli P, Maly FE. Macrolide treatment does not influence serum homocysteine in Chlamydia pneumoniae-seropositive patients suffering from atherosclerosis. Clin Chem. 2002 Sep;48(9):1631.

Seeger H, Petersen G, Schulte-Wintrop E, Teichmann AT, Mueck AO. Effect of two oral contraceptives containing ethinylestradiol and levonorgestrel on serum and urinary surrogate markers of endothelial function. Int J Clin Pharmacol Ther. 2002 Apr;40(4):150-7.

Segal R, Baumoehl Y, Elkayam O, Levartovsky D, Litinsky I, Paran D, Wigler I, Habot B, Leibovitz A, Sela BA, Caspi D. Anemia, serum vitamin B12, and folic acid in patients with rheumatoid arthritis, psoriatic arthritis, and systemic lupus erythematosus. Rheumatol Int. 2003 Apr 29

Sela BA. Homocysteine gets to the brain. Isr Med Assoc J. 2002 Mar;4(3):204-6.

Selhub J, Bagley LC, Miller J, Rosenberg IH. B vitamins, homocysteine, and neurocognitive function in the elderly. Am J Clin Nutr. 2000 Feb;71(2):614S-620S.

Selhub J. Folate, vitamin B12 and vitamin B6 and one carbon metabolism. J Nutr Health Aging. 2002;6(1):39-42. Review.

Selley ML. Increased concentrations of homocysteine and asymmetric dimethylarginine and decreased concentrations of nitric oxide in the plasma of patients with Alzheimer's disease. Neurobiol Aging. 2003 Nov;24(7):903-7.

Sen S, Oppenheimer SM, Lima J, Cohen B. Risk factors for progression of aortic atheroma in stroke and transient ischemic attack patients. Stroke. 2002 Apr;33(4):930-5.

Senaratne MP, MacDonald K, De Silva D. Possible ethnic differences in plasma homocysteine levels associated with coronary artery disease between south Asian and east Asian immigrants. Clin Cardiol. 2001 Nov;24(11):730-4.

Serafinowicz A, Kukula K, Cieciura T, Shaibani B, Baczkowska T, Soin J, Sadowska A, Nowacka-Cieciura E, Lewandowska D, Rell K, Durlik M, Lao M. Homocysteine and lipid peroxidation products: important atherosclerosis risk factors in renal allograft recipients? Transplant Proc. 2000 Sep;32(6):1367-8.

Selzman CH. Current approaches to therapy for vascular injury. Expert Opin Pharmacother. 2001 May;2(5):753-64. Review.

Seriolo B, Fasciolo D, Sulli A, Cutolo M. Homocysteine and antiphospholipid antibodies in rheumatoid arthritis patients: relationships with thrombotic events. Clin Exp Rheumatol. 2001 Sep-Oct;19(5):561-4.

Seshadri N, Robinson K. Homocysteine, B vitamins, and coronary artery disease. Med Clin North Am. 2000 Jan;84(1):215-37, x.

Sesmilo G, Biller BM, Llevadot J, Hayden D, Hanson G, Rifai N, Klibanski A. Effects of growth hormone (GH) administration on homocyst(e)ine levels in men with GH deficiency: a randomized controlled trial. J Clin Endocrinol Metab. 2001 Apr;86(4):1518-24.

Sessa C, Penillon S, Aubert A, Barro C, Ducros V, Pecher M, Guidicelli H, Magne JL. [Place of homocysteinemia in the treatment and the follow-up of lower-limb artherosclerotic disease] Ann Biol Clin (Paris). 2002 May-Jun;60(3):327-9. French.

Signorello MG, Pascale R, Leoncini G. Effect of homocysteine on arachidonic acid release in human platelets. Eur J Clin Invest. 2002 Apr;32(4):279-84.

Silverman MD, Tumuluri RJ, Davis M, Lopez G, Rosenbaum JT, Lelkes PI. Homocysteine upregulates vascular cell adhesion molecule-1 expression in cultured human aortic endothelial cells and enhances monocyte adhesion. Arterioscler Thromb Vasc Biol. 2002 Apr 1;22(4):587-92.

Sinzinger H, Chehne F, Schmid P, Kritz H. [Unaltered homocysteine levels during simvastatin therapy] Wien Klin Wochenschr. 2000 Jun 16;112(12):540-3. German.

Smith AD. Homocysteine, B vitamins, and cognitive deficit in the elderly. Am J Clin Nutr. 2002 May;75(5):785-6. Review.

Snavely J. Hyperhomocysteinemia in end stage renal disease: is treatment necessary? Nephrol Nurs J. 2002 Apr;29(2):155-60; quiz 161-2. Review.

Snehalatha C, Ramachandran A, Satyavani K, Sivasankari S, Sathyamurthy I, Viswanathan V. Plasma homocysteine concentration and coronary artery disease in Asian Indians. J Assoc Physicians India. 2002 Oct;50:1229-31.

Sobczak AJ. The effects of tobacco smoke on the homocysteine level--a risk factor of atherosclerosis. Addict Biol. 2003 Jun;8(2):147-58.

Slot O. Changes in plasma homocysteine in arthritis patients starting treatment with low-dose methotrexate subsequently supplemented with folic acid. Scand J Rheumatol. 2001;30(5):305-7.

SoRelle R. Folate reduces homocysteine levels and lowers rate of restenosis. Circulation. 2001 Dec 11;104(24):E9050-60.

Soysal D, Savas S, Susam I, Cevik C, Goldeli E, Sozmen E, Guneri S. The association of plasma homocysteine, coronary risk factors and serum nitrite in patients with coronary artery disease, vascular syndrome x and healthy subjects. Anadolu Kardiyol Derg. 2003 Mar;3(1):26-34, AXVIII-AXIX.

Stanford JL, Molina H, Phillips J, Kohlman-Trigoboff D, Moore J, Smith BM. Oral folate reduces plasma homocyst(e)ine levels in hemodialysis patients with cardiovascular disease. Cardiovasc Surg. 2000 Dec;8(7):567-71.

Stanger OH, Semmelrock HJ, Rehak P, Tiran B, Meinitzer A, Rigler B, Tiran A. Hyperhomocyst(e)inemia and Chlamydia pneumoniae IgG seropositivity in patients with coronary artery disease. Atherosclerosis. 2002 May;162(1):157-62.

Stanger O, Semmelrock HJ, Wonisch W, Bos U, Pabst E, Wascher TC. Effects of folate treatment and homocysteine lowering on resistance vessel reactivity in atherosclerotic subjects. J Pharmacol Exp Ther. 2002 Oct;303(1):158-62.

Stanger O, Weger M, Renner W, Konetschny R. Vascular dysfunction in hyperhomocyst(e)inemia. Implications for atherothrombotic disease. Clin Chem Lab Med. 2001 Aug;39(8):725-33. Review.

Stangl V, Gunther C, Jarrin A, Bramlage P, Moobed M, Staudt A, Baumann G, Stangl K, Felix SB. Homocysteine inhibits TNF-alpha-induced endothelial adhesion molecule expression and monocyte adhesion via nuclear factor-kappaB dependent pathway. Biochem Biophys Res Commun. 2001 Feb 2;280(4):1093-100.

Stangl V, Baumann G, Stangl K. Coronary atherogenic risk factors in women.Eur Heart J. 2002 Nov;23(22):1738-52. Review.

Stangl K, Cascorbi I, Stangl V, Laule M, Dschietzig T, Richter C, Felix SB, Roots I, Baumann G. Hyperhomocysteinaemia and adverse events complicating coronary catheter interventions. Int J Cardiol. 2000 Nov-Dec;76(2-3):211-7.

Stehouwer DA. Clinical relevance of hyperhomocysteinaemia in atherothrombotic disease. Drugs Aging. 2000 Apr;16(4):251-60. Review.

Stewart R, Asonganyi B, Sherwood R. Plasma homocysteine and cognitive impairment in an older British African-Caribbean population. J Am Geriatr Soc. 2002 Jul;50(7):1227-32.

Streck EL, Vieira PS, Wannmacher CM, Dutra-Filho CS, Wajner M, Wyse AT. In vitro effect of homocysteine on some parameters of oxidative stress in rat hippocampus. Metab Brain Dis. 2003 Jun;18(2):147-54.

Streifler JY, Rosenberg N, Chetrit A, Eskaraev R, Sela BA, Dardik R, Moghadasian MH, McManus BM, Nguyen LB, Shefer S, Nadji M, Godin DV, Green TJ, Hill J, Yang Y, Scudamore CH, Frohlich JJ. Pathophysiology of apolipoprotein E deficiency in mice: relevance to apo E-related disorders in humans. FASEB J. 2001 Dec;15(14):2623-30.

Stuhlinger MC, Tsao PS, Her JH, Kimoto M, Balint RF, Cooke JP. Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine. Circulation. 2001 Nov 20;104(21):2569-75.

Stulc T, Melenovsky V, Grauova B, Kozich V, Ceska R. Folate supplementation prevents plasma homocysteine increase after fenofibrate therapy. Nutrition. 2001 Sep;17(9):721-3.

Suarez Garcia I, Gomez Cerezo JF, Rios Blanco JJ, Barbado Hernandez FJ, Vazquez Rodriguez JJ. [Homocysteine. The cardiovascular risk factor of the next millennium?] An Med Interna. 2001 Apr;18(4):211-7. Review. Spanish.

Suliman ME, Stenvinkel P, Barany P, Heimburger O, Anderstam B, Lindholm B. Hyperhomocysteinemia and its relationship to cardiovascular disease in ESRD: influence of hypoalbuminemia, malnutrition, inflammation, and diabetes mellitus. Am J Kidney Dis. 2003 Mar;41(3 Suppl 2):S89-95. Review.

Sunder-Plassmann G, Fodinger M, Buchmayer H, Papagiannopoulos M, Wojcik J, Kletzmayr J, Enzenberger B, Janata O, Winkelmayer WC, Paul G, Auinger M, Barnas U, Horl WH. Effect of high dose folic acid therapy on hyperhomocysteinemia in hemodialysis patients: results of the Vienna multicenter study. J Am Soc Nephrol. 2000 Jun;11(6):1106-16.

Sung FL, Slow YL, Wang G, Lynn EG, O K. Homocysteine stimulates the expression of monocyte chemoattractant protein-1 in endothelial cells leading to enhanced monocyte chemotaxis. Mol Cell Biochem. 2001 Jan;216(1-2):121-8.

Superko HR, Hecht HS. Metabolic disorders contribute to subclinical coronary atherosclerosis in patients with coronary calcification. Am J Cardiol. 2001 Aug 1;88(3):260-4.

Svenungsson E, Jensen-Urstad K, Heimburger M, Silveira A, Hamsten A, de Faire U, Witztum JL, Frostegard J. Risk factors for cardiovascular disease in systemic lupus erythematosus. Circulation. 2001 Oct 16;104(16):1887-93.

Sydor A, Drozdz M, Krasniak A, Milkowski A, Chmiel G, Malczak J, Zabawa-Holys S, Moskal K, Podwysocki A, Szmigielski M, Czarnecka D, Gozdecka H, Kowalczyk-Michalek M, Szczeklik A, Wiecek A, Sulowicz W. [Hyperhomocysteinemia and advancement of atherosclerosis in patients with chronic renal failure on maintenance hemodialysis] Przegl Lek. 2002;59(12):962-7. Polish.

Szczeklik A, Sanak M, Jankowski M, Dropinski J, Czachor R, Musial J, Axenti I, Twardowska M, Brzostek T, Tendera M. Mutation A1298C of methylenetetrahydrofolate reductase: risk for early coronary disease not associated with hyperhomocysteinemia. Am J Med Genet. 2001 Jun 1;101(1):36-9.

Takamitsu Y, Nakanishi T. Association of endothelial dysfunction with sulfur amino acid metabolism in chronic renal failure. Am J Kidney Dis. 2001 Oct;38(4 Suppl 1):S95-9. Review.

Takeichi S, Nakajima Y, Yukawa N, Saito T, Seto Y, Huang XL, Kusakabe T, Jin ZB, Hasegawa I, Nakano T, Saniabadi A, Adachi M, Ohara N, Wang T, Nakajima K. Plasma triglyceride-rich lipoprotein remnants as a risk factor of 'Pokkuri disease'. Leg Med (Tokyo). 2001 Jun;3(2):84-94.

Tamura A, Fujioka T, Nasu M. Relation of Helicobacter pylori infection to plasma vitamin B12, folic acid, and homocysteine levels in patients who underwent diagnostic coronary arteriography. Am J Gastroenterol. 2002 Apr;97(4):861-6.

Temple ME, Luzier AB, Kazierad DJ. Homocysteine as a risk factor for atherosclerosis. Ann Pharmacother. 2000 Jan;34(1):57-65.

Teplan V, Schuck O, Stollova M, Vitko S. Obesity and hyperhomocysteinaemia after kidney transplantation. Nephrol Dial Transplant. 2003 Jul;18 Suppl 5:v71-3

Teunissen CE, Blom AH, Van Boxtel MP, Bosma H, De Bruijn C, Jolles J, Wauters BA, Steinbusch HW, De Vente J. Homocysteine: a marker for cognitive performance? A longitudinal follow-up study. J Nutr Health Aging. 2003;7(3):153-9.

Teunissen CE, van Boxtel MP, Bosma H, Jolles J, Lutjohann D, von Bergmann K, Wauters A, Bosmans E, Maes M, Delanghe J, De Bruijn C, Steinbusch HW, Blom HJ, de Vente J. [Serum markers in relation to cognitive functioning in an aging population: results of the Maastricht Aging Study (MAAS)] Tijdschr Gerontol Geriatr. 2003 Feb;34(1):6-12. Dutch.

Thambyrajah J, Landray MJ, McGlynn FJ, Jones HJ, Wheeler DC, Townend JN. Does folic acid decrease plasma homocysteine and improve endothelial function in patients with predialysis renal failure? Circulation. 2000 Aug 22;102(8):871-5.

Thambyrajah J, Townend JN. Homocysteine and atherothrombosis--mechanisms for injury. Eur Heart J. 2000 Jun;21(12):967-74. Review.

Theuma P, Fonseca VA. Inflammation and emerging risk factors in diabetes mellitus and atherosclerosis. Curr Diab Rep. 2003 Jun;3(3):248-54. Review.

Title LM, Cummings PM, Giddens K, Genest JJ Jr, Nassar BA. Effect of folic acid and antioxidant vitamins on endothelial dysfunction in patients with coronary artery disease. J Am Coll Cardiol. 2000 Sep;36(3):758-65.

Tonstad S, Smerud K, Hoie L. A comparison of the effects of 2 doses of soy protein or casein on serum lipids, serum lipoproteins, and plasma total homocysteine in hypercholesterolemic subjects. Am J Clin Nutr. 2002 Jul;76(1):78-84.

Torre Delgadillo A, Tellez Zenteno JF, Morales Buenrrostro LE. [Hyperhomocysteinaemia: physiopathology and medical implications] Rev Invest Clin. 2000 Sep-Oct;52(5):557-64. Review. Spanish.

Tribouilloy CM, Peltier M, Iannetta Peltier MC, Trojette F, Andrejak M, Lesbre JP. Plasma homocysteine and severity of thoracic aortic atherosclerosis. Chest. 2000 Dec;118(6):1685-9.

Tsai WC, Li YH, Tsai LM, Chao TH, Lin LJ, Chen TY, Chen JH. Correlation of homocytsteine levels with the extent of coronary atherosclerosis in patients with low cardiovascular risk profiles. Am J Cardiol. 2000 Jan 1;85(1):49-52.

Tsutsumi Z, Moriwaki Y, Yamamoto T, Takahashi S, Hada T, Fukuchi M. Total plasma homocysteine is not increased in Japanese patients with gout. J Rheumatol. 2002 Aug;29(8):1805-6.

Tumer L, Serdaroglu A, Hasanoglu A, Biberoglu G, Aksoy E. Plasma homocysteine and lipoprotein (a) levels as risk factors for atherosclerotic vascular disease in epileptic children taking anticonvulsants. Acta Paediatr. 2002;91(9):923-6.

Ubbink JB, Delport R. Homocysteine as atherothrombotic agent: is the bark worse than the bite? Nutrition. 2000 Jul-Aug;16(7-8):672-4.

van Aken BE, Jansen J, van Deventer SJ, Reitsma PH. Elevated levels of homocysteine increase IL-6 production in monocytic Mono Mac 6 cells. Blood Coagul Fibrinolysis. 2000 Mar;11(2):159-64.

van Asselt DZ, Pasman JW, van Lier HJ, Vingerhoets DM, Poels PJ, Kuin Y, Blom HJ, Hoefnagels WH. Cobalamin supplementation improves cognitive and cerebral function in older, cobalamin-deficient persons. J Gerontol A Biol Sci Med Sci. 2001 Dec;56(12):M775-9.

van den Brandhof WE, Haks K, Schouten EG, Verhoef P. The relation between plasma cysteine, plasma homocysteine and coronary atherosclerosis. Atherosclerosis. 2001 Aug;157(2):403-9.

van Ede AE, Laan RF, De Abreu RA, Stegeman AB, van de Putte LB. Purine enzymes in patients with rheumatoid arthritis treated with methotrexate. Ann Rheum Dis. 2002 Dec;61(12):1060-4.

van Ede AE, Laan RF, Blom HJ, Boers GH, Haagsma CJ, Thomas CM, De Boo TM, van de Putte LB. Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis. Rheumatology (Oxford). 2002 Jun;41(6):658-65.

van Ede AE, Laan RF, Blom HJ, Huizinga TW, Haagsma CJ, Giesendorf BA, de Boo TM, van de Putte LB. The C677T mutation in the methylenetetrahydrofolate reductase gene: a genetic risk factor for methotrexate-related elevation of liver enzymes in rheumatoid arthritis patients. Arthritis Rheum. 2001 Nov;44(11):2525-30.

van Guldener C, Robinson K. Homocysteine and renal disease. Semin Thromb Hemost. 2000;26(3):313-24. Review.

van Guldener C, Stehouwer CD. Hyperhomocysteinemia, vascular pathology, and endothelial dysfunction. Semin Thromb Hemost. 2000;26(3):281-9. Review.

Vanharanta M, Voutilainen S, Nurmi T, Kaikkonen J, Roberts LJ, Morrow JD, Adlercreutz H, Salonen JT. Association between low serum enterolactone and increased plasma F2-isoprostanes, a measure of lipid peroxidation. Atherosclerosis. 2002 Feb;160(2):465-9.

Ventura P, Panini R, Verlato C, Scarpetta G, Salvioli G. Hyperhomocysteinemia and related factors in 600 hospitalized elderly subjects. Metabolism. 2001 Dec;50(12):1466-71.

500. Verhaar MC, Stroes E, Rabelink TJ. Folates and cardiovascular disease. Arterioscler Thromb Vasc Biol. 2002 Jan;22(1):6-13. Review.

Verhoef P. Hyperhomocysteinemia and risk of vascular disease in women. Semin Thromb Hemost. 2000;26(3):325-34. Review.

Vermeulen EG, Stehouwer CD, Twisk JW, van den Berg M, de Jong SC, Mackaay AJ, van Campen CM, Visser FC, Jakobs CA, Bulterjis EJ, Rauwerda JA. Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial. Lancet. 2000 Feb 12;355(9203):517-22.

Vermeulen EG, Niessen HW, Bogels M, Stehouwer CD, Rauwerda JA, van Hinsbergh VW. Decreased smooth muscle cell/extracellular matrix ratio of media of femoral artery in patients with atherosclerosis and hyperhomocysteinemia. Arterioscler Thromb Vasc Biol. 2001 Apr;21(4):573-7.

Vermeulen EG, Rauwerda JA, van den Berg M, de Jong SC, Schalkwijk C, Twisk JW, Stehouwer CD. Homocysteine-lowering treatment with folic acid plus vitamin B6 lowers urinary albumin excretion but not plasma markers of endothelial function or C-reactive protein: further analysis of secondary end-points of a randomized clinical trial. Eur J Clin Invest. 2003 Mar;33(3):209-15.

Virdis A, Ghiadoni L, Cardinal H, Favilla S, Duranti P, Birindelli R, Magagna A, Bernini G, Salvetti G, Taddei S, Salvetti A. Mechanisms responsible for endothelial dysfunction induced by fasting hyperhomocystinemia in normotensive subjects and patients with essential hypertension. J Am Coll Cardiol. 2001 Oct;38(4):1106-15

Vrhovski-Hebrang D, Flegar-Mestric Z, Preden-Kerekovic V, Perkov S, Hebrang A, Janus D, Grga A. Biochemical risk factors in angiographically established stenosis of cerebral arteries. Croat Med J. 2002 Dec;43(6):696-701.

Wallberg-Jonsson S, Cvetkovic JT, Sundqvist KG, Lefvert AK, Rantapaa-Dahlqvist S. Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis. J Rheumatol. 2002 May;29(5):875-82.

Wang XL, Oosterhof J. Tumour necrosis factor alpha G-308-->A polymorphism and risk for coronary artery disease. Clin Sci (Lond). 2000 Apr;98(4):435-7.

Wang G, O K. Homocysteine stimulates the expression of monocyte chemoattractant protein-1 receptor (CCR2) in human monocytes: possible involvement of oxygen free radicals. Biochem J. 2001 Jul 1;357(Pt 1):233-40.

Wang H, Jiang X, Yang F, Gaubatz JW, Ma L, Magera MJ, Yang X, Berger PB, Durante W, Pownall HJ, Schafer AI. Hyperhomocysteinemia accelerates atherosclerosis in cystathionine beta-synthase and apolipoprotein E double knock-out mice with and without dietary perturbation. Blood. 2003 May 15;101(10):3901-7.

Wang G, Woo CW, Sung FL, Siow YL, O K. Increased monocyte adhesion to aortic endothelium in rats with hyperhomocysteinemia: role of chemokine and adhesion molecules. Arterioscler Thromb Vasc Biol. 2002 Nov 1;22(11):1777-83.

Wanner C, Metzger T. C-reactive protein a marker for all-cause and cardiovascular mortality in haemodialysis patients. Nephrol Dial Transplant. 2002;17 Suppl 8:29-32; discussion 39-40. Review.

Wasilewska A, Narkiewicz M, Rutkowski B, Lysiak-Szydlowska W. Is there any relationship between lipids and vitamin B levels in persons with elevated risk of atherosclerosis? Med Sci Monit. 2003 Mar;9(3):CR147-51.

Weisberg IS, Park E, Ballman KV, Berger P, Nunn M, Suh DS, Breksa AP 3rd, Garrow TA, Rozen R. Investigations of a common genetic variant in betaine-homocysteine methyltransferase (BHMT) in coronary artery disease. Atherosclerosis. 2003 Apr;167(2):205-14.

Weiss N, Keller C, Hoffmann U, Loscalzo J. Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia. Vasc Med. 2002 Aug;7(3):227-39. Review.

Werstuck GH, Lentz SR, Dayal S, Hossain GS, Sood SK, Shi YY, Zhou J, Maeda N, Krisans SK, Malinow MR, Austin RC. Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J Clin Invest. 2001 May;107(10):1263-73.

West SG. Effect of diet on vascular reactivity: an emerging marker for vascular risk. Curr Atheroscler Rep. 2001 Nov;3(6):446-55. Review.

Whitmer RA, Haan MN, Miller JW, Yaffe K. Hormone replacement therapy and cognitive performance: the role of homocysteine. J Gerontol A Biol Sci Med Sci. 2003 Apr;58(4):324-30.

Wierzbicki P, Prokopiuk M, Kade G, Wankowicz Z. [Biochemical risk factor for atherosclerosis in young men. Preliminary report] Pol Arch Med Wewn. 2001 Nov;106(5):1019-27. Polish.

Willcox JK, Catignani GL, Lazarus S. Tomatoes and cardiovascular health. Crit Rev Food Sci Nutr. 2003;43(1):1-18. Review.

Williams JH, O'Connell TC. Differential relations between cognition and 15N isotopic content of hair in elderly people with dementia and controls. J Gerontol A Biol Sci Med Sci. 2002 Dec;57(12):M797-802.

Williams JH, Pereira EA, Budge MM, Bradley KM. Minimal hippocampal width relates to plasma homocysteine in community-dwelling older people. Age Ageing. 2002 Nov;31(6):440-4.

Willinek WA, Ludwig M, Lennarz M, Holler T, Stumpe KO. High-normal serum homocysteine concentrations are associated with an increased risk of early atherosclerotic carotid artery wall lesions in healthy subjects. J Hypertens. 2000 Apr;18(4):425-30.

Wilmink HW, Stroes ES, Erkelens WD, Gerritsen WB, Wever R, Banga JD, Rabelink TJ. Influence of folic acid on postprandial endothelial dysfunction. Arterioscler Thromb Vasc Biol. 2000 Jan;20(1):185-8.

Wittenstein B, Klein M, Finckh B, Ullrich K, Kohlschutter A. Plasma antioxidants in pediatric patients with glycogen storage disease, diabetes mellitus, and hypercholesterolemia. Free Radic Biol Med. 2002 Jul 1;33(1):103-10.

Wittenstein B, Klein M, Finckh B, Ullrich K, Kohlschutter A. Radical trapping in glycogen storage disease 1a. Eur J Pediatr. 2002 Oct;161 Suppl 1:S70-4.

Wocial B, Berent H, Kostrubiec M, Kuczynska K, Kuch-Wocial A, Nieweglowska N. Homocysteine, adrenergic activity and left ventricular mass in patients with essential hypertension. Blood Press. 2002;11(4):201-5.

Woo DK, Dudrick SJ, Sumpio BE. Homocysteine stimulates MAP kinase in bovine aortic smooth muscle cells. Surgery. 2000 Jul;128(1):59-66.

Woo KS, Chook P, Chan LL, Cheung AS, Fung WH, Qiao M, Lolin YI, Thomas GN, Sanderson JE, Metreweli C, Celermajer DS. Long-term improvement in homocysteine levels and arterial endothelial function after 1-year folic acid supplementation. Am J Med. 2002 May;112(7):535-9.

Woo CW, Cheung F, Chan VW, Siow YL, O K. Homocysteine stimulates inducible nitric oxide synthase expression in macrophages: antagonizing effect of ginkgolides and bilobalide. Mol Cell Biochem. 2003 Jan;243(1-2):37-47.

Xu D, Neville R, Finkel T. Homocysteine accelerates endothelial cell senescence. FEBS Lett. 2000 Mar 17;470(1):20-4.

Yen PK. Maintaining cognitive function with diet. Geriatr Nurs. 2003 Jan-Feb;24(1):62-3.

Yeromenko Y, Lavie L, Levy Y. Homocysteine and cardiovascular risk in patients with diabetes mellitus. Nutr Metab Cardiovasc Dis. 2001 Apr;11(2):108-16. Review.

Yeun JY, Kaysen GA. C-reactive protein, oxidative stress, homocysteine, and troponin as inflammatory and metabolic predictors of atherosclerosis in ESRD. Curr Opin Nephrol Hypertens. 2000 Nov;9(6):621-30. Review.

Yildirir A, Tokgozoglu SL, Haznedaroglu I, Sinici I, Kabakci G, Ovunc K, Aksoyek S, Oto A, Ozmen F, Kirazli S, Kes S. Extent of coronary atherosclerosis and homocysteine affect endothelial markers. Angiology. 2001 Sep;52(9):589-96.

Yoo JH, Choi GD, Kang SS. Pathogenicity of thermolabile methylenetetrahydrofolate reductase for vascular dementia. Arterioscler Thromb Vasc Biol. 2000 Aug;20(8):1921-5.

Yoshino N, Adachi K, Takashima T, Miyaoka Y, Yuki T, Ishihara S, Kinoshita Y. Helicobacter pylori infection does not affect the serum level of homocysteine. Am J Gastroenterol. 2002 Nov;97(11):2927-8.

Yu Y, Hou F, Zhou H, Yang Y, Zhang X, Yang L, Hu M. [The role of hyperhomocysteinemia on atherosclerosis in patients with chronic renal failure] Zhonghua Nei Ke Za Zhi. 2002 Aug;41(8):517-21. Chinese.

Yu HH, Joubran R, Asmi M, Law T, Spencer A, Jouma M, Rifai N. Agreement among four homocysteine assays and results in patients with coronary atherosclerosis and controls. Clin Chem. 2000 Feb;46(2):258-64

Zacarias-Castillo R, Hernandez-Rebollar AE, Zajarias-Rabchinskey A, Gonzalez-Barcena D. [Hyperhomocysteinemia. A new coronary risk factor] Gac Med Mex. 2001 Jul-Aug;137(4):335-45. Review. Spanish.

Zairis MN, Ambrose JA, Manousakis SJ, Stefanidis AS, Papadaki OA, Bilianou HI, DeVoe MC, Fakiolas CN, Pissimissis EG, Olympios CD, Foussas SG; Global Evaluation of New Events and Restenosis After Stent Implantation Study Group. The impact of plasma levels of C-reactive protein, lipoprotein (a) and homocysteine on the long-term prognosis after successful coronary stenting: The Global Evaluation of New Events and Restenosis After Stent Implantation Study. J Am Coll Cardiol. 2002 Oct 16;40(8):1375-82.

Zak I, Niemiec P, Sarecka B, Balcerzyk A, Ciemniewski Z, Rudowska E, Dylag S. Carrier-state of D allele in ACE gene insertion/deletion polymorphism is associated with coronary artery disease, in contrast to the C677-->T transition in the MTHFR gene. Acta Biochim Pol. 2003;50(2):527-34.

Zappacosta B, Mordente A, Persichilli S, Giardina B, De Sole P. Effect of homocysteine on polymorphonuclear leukocyte activity and luminol-dependent chemiluminescence. Luminescence. 2000 Jul-Aug;15(4):257-60.

Zappacosta B, Mordente A, Persichilli S, Minucci A, Carlino P, Martorana GE, Giardina B, De Sole P. Is homocysteine a pro-oxidant? Free Radic Res. 2001 Nov;35(5):499-505.

Zhang Q, Zeng X, Guo J, Wang X. Effects of homocysteine on murine splenic B lymphocyte proliferation and its signal transduction mechanism. Cardiovasc Res. 2001 Nov;52(2):328-36.

Zhang HS, Cao EH, Qin JF. Intracellular redox status modulates monocyte chemoattractant protein-1 expression stimulated by homocysteine in endothelial cells. J Cardiovasc Pharmacol. 2003 Aug;42(2):258-65.

Zhang Q, Zeng X, Guo J, Wang X. Oxidant stress mechanism of homocysteine potentiating Con A-induced proliferation in murine splenic T lymphocytes. Cardiovasc Res. 2002 Mar;53(4):1035-42.

Zhang G, Dai C. Gene polymorphisms of homocysteine metabolism-related enzymes in Chinese patients with occlusive coronary artery or cerebral vascular diseases. Thromb Res. 2001 Nov 1;104(3):187-95.

Zhou J, Moller J, Ritskes-Hoitinga M, Larsen ML, Austin RC, Falk E. Effects of vitamin supplementation and hyperhomocysteinemia on atherosclerosis in apoE-deficient mice. Atherosclerosis. 2003 Jun;168(2):255-62.

Zhou J, Moller J, Danielsen CC, Bentzon J, Ravn HB, Austin RC, Falk E. Dietary supplementation with methionine and homocysteine promotes early atherosclerosis but not plaque rupture in ApoE-deficient mice. Arterioscler Thromb Vasc Biol. 2001 Sep;21(9):1470-6.

Zivelin A, Ravid B, Davidson J, Seligsohn U, Inbal A. Cerebrovascular events in patients with significant stenosis of the carotid artery are associated with hyperhomocysteinemia and platelet antigen-1 (Leu33Pro) polymorphism. Stroke. 2001 Dec 1;32(12):2753-8.

Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Fermo I, Foca A, Paroni R, Malatino LS. Inflammation is associated with carotid atherosclerosis in dialysis patients. Creed Investigators. Cardiovascular Risk Extended Evaluation in Dialysis Patients. J Hypertens. 2000 Sep;18(9):1207-13.

Zulli A, Widdop RE, Hare DL, Buxton BF, Black MJ. High methionine and cholesterol diet abolishes endothelial relaxation. Arterioscler Thromb Vasc Biol. 2003 Aug 1;23(8):1358-63. Epub 2003 Jun 05.